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ABSTRACT 
SUSAN KAY RANSOM COLLINS:  Associations between Frailty and Sex, and Frailty and 
Race in Hospitalized Chronic Heart Failure Patients: An Exploratory Study 
(Under the direction of Mary H. Palmer) 
 
Using a descriptive correlational design, a secondary analysis was conducted to explore 
frailty in hospitalized heart failure (HF) patients.  This study examined differences in a) frailty 
and sex, b) frailty and race, and c) relationships between frailty and comorbidity, depression, 
disability, health status, and urinary incontinence.  Frailty was determined by the presence of at 
least three of the five following criteria: BMI <18.5 kg/m2 or >30.0 kg/m2; albumin <3.8 g/dl;  
hemoglobin <13.5 g/dl for men or <12.5 g/dl for women, and NYHA class III or IV HF and/or 
ejection fraction <40%.  The sample consisted of 154 HF patients 50-94 years old who were 
admitted to the Heart Failure Center of a large teaching hospital.   
Results. Overall prevalence of frailty in HF patients was 38% (58/154).  Female subjects 
were approximately 3 times more likely to be frail (OR=3.38, 95% CI =1.57 to 7.31; p=.002) and 
frail females were 27 times more likely to be anemic (OR=26.85, 95% CI=10.78 to 66.88; 
p<.0001) compared to males, when stratified by age group.  Significant differences in the odds of 
being anemic or in late HF found in HF patients by race did not persist in frail HF patients.  
Significant (p=.05) differences in Late HF occurred in 80% (32 out of 40) of older (over 65 
years) males compared to 60% (22 out of 37) older females.  Self-report of poor health increased 
the likelihood of frailty more than three times that of self- report of  excellent to fair health 
(OR=3.57, 95%CI=1.56 to 8.14; p=.002). Subjects with two or more 
iv
additional chronic illnesses were more than five times more likely to be frail (OR=5.36, 
95%CI=1.85 to 15.49; p=.042). 
Conclusion: Significant differences in prevalence and frequency of frailty characteristics 
by sex but not by race suggest that males and females develop frailty by different pathways.  
Anemia was found to be an important indicator of frailty in women and could be a significant 
factor in the ability of females to respond to physical therapy.  Further study is needed to 
determine whether similar indicators can be found for males or by race.  
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CHAPTER I 
 
INTRODUCTION 
 
Frailty has recently been recognized as a geriatric syndrome (Fried, 1999) that is 
associated with increased vulnerability of an individual when even a small increase in 
environmental demand results in adverse health outcomes such as dependency, 
institutionalization, falls, injury, or premature death (Fried, 1999).  This chapter begins with a 
statement of the problem the current healthcare system faces in meeting the needs of a rapidly 
increasing population of older adults susceptible to frailty, which is followed by a discussion of 
the significance of the problem and why it is important to study frailty.  Next, the background for 
this study begins with a brief introduction to the Cycle of Frailty (Fried, Tangen, Walston, 
Newman, et al., 2001) the conceptual model for this study, which is followed by an overview of 
some of the early scholarly work that laid the foundation for the current understanding of frailty. 
Finally, there is a brief discussion of the association between heart failure (HF) and frailty, frailty 
and sex, and frailty and race. 
Statement of the Problem 
There is a critical need to understand and predict the healthcare needs of the rapidly-
increasing population of older adults in the United States (U.S.).  As advances in medical 
technology reduce risks of death from acute illness, the risks increase for acquiring chronic 
illnesses or developing geriatric syndromes as a result of living longer (Fries, 2005).  Thus, with 
longevity comes the risk of a prolonged downward trajectory for health and quality of life.  One 
consequence of declining health is frailty: a state of vulnerability to environmental
2changes such as illness, loss, and/or relocation (Buchner & Wagner, 1992; Fried et al., 2001).  An 
important step toward improving quality of life and reducing the period of infirmity for older 
adults is to recognize and understand frailty in the presence of chronic illness.  
Significance 
One of the most common chronic illnesses in the elderly is HF (Center for Disease 
Control [CDC], 2006), and there is a strong association between frailty and HF.  Progressive 
activity intolerance resulting in an inability to complete basic activities of daily living is a 
characteristic of worsening HF and is also the main discriminator between the four classes of the 
New York Heart Association’s (NYHA, 1994) classification system for HF.  The severity of HF 
symptoms are measured on a scale of I – IV, where Class I indicates a patient with underlying 
cardiac disease but without activity limitations due to symptoms of HF, and Class IV indicates 
the presence of severe symptoms of HF even at rest (NYHA).   
Progressive activity intolerance associated with HF places older adults at a higher risk for 
frailty. Older adults are especially susceptible to frailty when medical treatments or illness 
restrict mobility, require prolonged immobility, or impose dietary and fluid restrictions (Creditor, 
1993; Fretwell, 1990; Fried & Walston, 2003) as is common in the treatment of HF.  It is not 
surprising that a strong association between HF and frailty has been demonstrated.  For example, 
one study of 4,735 community dwelling older adults found that those who were in HF were over 
seven times more likely to meet the criteria for frailty than those with other forms of 
cardiovascular disease (Newman et al., 2001).  Even so, frailty will often go unrecognized in HF 
patients until an acute illness, or exacerbation of HF, begins a cascade of catastrophic decline 
associated with frailty (Cacciatore et al., 2005; Fretwell, 1990; Fried, 1999; Lachs, et al., 1990).  
Furthermore, subjects who are frail and not in HF are more likely than those who are not frail to 
experience catastrophic events or adverse health outcomes such as prolonged hospital stays and 
higher rates of admission to long term care facilities (Hancock, Chang, Chenoweth, Clarke, 
3Carroll & Jeon, 2003; Inouye, Bogardus, Baker, Leo-Summers, & Cooney, 2000).  Although it is 
thought that increased vulnerability and lack of resilience, which are hallmarks of frailty, are 
responsible for these adverse outcomes (Fried & Walston, 2003), further investigations of factors 
that contribute to frailty in the presence of HF are warranted for several reasons.       
First, U.S. census data indicate that adults 65 years and older are experiencing the 
greatest population growth, are the highest users of acute care, and have the worst health 
outcomes (CDC, 2006) when compared to other segments of the population.  National Hospital 
Survey data also indicate that heart disease is the primary cause of death in people over 65, and 
an estimated 77% of older adults discharged from the hospital have a diagnosis of HF (Kojak, 
Owings, & Hall, 2004). In 1979 there were 399,000 discharges and in 2003 there were 1,093,000 
discharges with HF (Kojak et al), more than doubling over the course of 24 years.  When frailty 
is coupled with HF, the trajectory for HF becomes more acute and debilitating. In a study of 
frailty and HF, Cacciatore et al. (2005) used the frailty staging system to measure the level of 
frailty in a population of older adults.  They found that none of the subjects with advanced frailty 
survived past nine years, and only 10% of subjects who were frail without HF survived past 11 
years (Cacciatore et al.).   In contrast, those who met NYHA criteria for Class IV HF, but did not 
meet the criteria for frailty, based on the frailty staging system, were still alive at the11 year 
follow-up (Cacciatore et al.).   
Second, older adults should not be destined to spend more years in poor health with 
disabilities that compromise their independence and autonomy (Fries, 2005) as a result of 
advances in medical technology.  In fact, one of the goals of the national health plan, Healthy 
People 2010, is to increase both “the quality and years of healthy life” (United States Department 
of Health and Human Services [DHHS], 2002).  Primary and secondary prevention strategies to 
postpone the onset of chronic illness (including frailty) have been proposed as an important 
approach for reducing the period of infirmity preceding death (US DHHS, 2002).
4Third, the cost of treating HF is great in terms of health care and financial resources.  For 
example, in 2001 an estimated $4.0 billion was paid by Medicare for treatment of HF (American 
Heart Association [AHA], 2005).  Currently, life expectancy after the age of 65 years is greater 
for women (19 years) than for men (16 years) (O’Neill & Patrick, 2002), leaving many older 
women widowed with limited financial or social support.  This places the greatest burden of 
illness and functional loss on older women when they have the fewest resources available to 
respond to environmental, physiological, or social demands placed on them.  
Finally, race may also be a factor in HF and frailty.  According to the American Heart 
Association (AHA, 2005) there is a higher prevalence of HF in Blacks than Whites.  
Furthermore, one study found Blacks to be four times more likely to be frail compared to Whites 
(Hirsh et al., 2006).   Therefore, when examining frailty in the presence of HF, race should also 
be examined.  
Therefore the purpose of this exploratory study was to examine frailty in HF patients and 
to describe the relationships between 1) frailty and sex, 2) frailty and race, and 3) the influence of 
sex and race on the relationships between frailty and depression, functional status, health status, 
comorbidity (more than two additional chronic illnesses), and uriniary incontinence found in 
hospitalized HF patients.  Results may provide vital information to assist nurses to better identify 
those at risk of being frail, identify those who are frail at an earlier stage, and target treatment 
strategies to maintain optimal quality of life and reduce the time of infirmity for older adults prior 
to death. 
Background 
 Until recently, frailty has been recognized only after the fact, when the inability of an 
older adult to recover from a seemingly innocuous event cannot be explained.  The term frailty 
has been used synonymously with disability, comorbidity (accumulation of chronic illnesses), 
extreme old age, and as a sample characteristic without being clearly defined (Markle-Reid & 
5Browne, 2005). More recently, frailty has been used to describe older adults who seem “to be at 
greatest risk of falling, developing medical complications, losing independence, and dying” 
(Walston, 2005, p. 84).  When associated with the aging process (especially when age is greater 
than 70 years), disability, and multiple chronic illnesses, frailty has been thought by some to be 
an inevitable part of growing old.  However, frailty has been found to be reversible when factors 
related to nutrition and mobility were addressed (Gill, Baker Bottschalk, Peduzzi, et al., 2002), 
suggesting that frailty is not inevitable.   The conceptual model developed by Fried and 
colleagues (2001) indicates that there may be three key physiological systems that are involved in 
the progression of functional decline associated with frailty, 1) chronic undernutrition and 
decreased metabolism of nutrients, 2) sarcopenia (muscle wasting) and reduced strength and 
endurance, and 3) reduced energy expenditure and low activity level.  
Conceptual Model 
Fried and colleagues (2001) hypothesized that frailty involves multiple physiological 
systems that are related by a cycle of progressive decline in physiological reserves needed to 
maintain health and well-being of the human organism.  An oversimplified explanation of their 
model of this cycle describes a process in which chronic undernutrition results in a significant 
loss of lean body mass (sarcopenia) and decline in endurance (energy needed to be active), which 
leads to a slowing down of metabolism, thus decreasing energy expenditure.  The process could 
just as easily start with a decline in basal metabolism or energy expenditure, subsequent decline 
in physiological demand for nutrients, which can act as an appetite suppressant, or altered 
metabolism of nutrients.   
Antecedents to entering into the cycle of frailty include changes in the neuro-
musculoskeletal system brought on by aging, a sedentary lifestyle and low activity, comorbidity, 
disability that limits activity, and diseases accompanied by organ compromise, to name a few 
6(Fried et al., 2001).  The criteria Fried and colleagues found to best define frailty in their study 
include an indicator for the impact of chronic undernutrition (unintentional weight loss), three 
indicators for declining strength and endurance (grip strength, walking speed, exhaustion), and an 
indicator for slower metabolism or decreased energy expenditure (low activity).  Risk factors for 
frailty can be recognized as factors that lead to malnutrition, muscle wasting and lost endurance, 
or reduced activity.  Known risk factors include depression, illness that leads to prolonged bed 
rest or activity restrictions, medications that cause feelings of lethargy, and functional changes or 
disability that limit activity (Figure 1).   
 
As the conceptual model for this study, the Cycle of Frailty guided the selection process 
for the variables and research methods, which is discussed in detail in Chapter III.  This model 
was also used as the framework in this study to explore relationships between frailty and sex and 
frailty and race in terms of prevalence, number and type of frailty characteristics.  Construct 
Chronic 
Undernutrition 
Weight Loss 
ENERGY 
DEFICIENCY 
 
SARCOPENIA 
 TOTAL ENERGY 
EXPENDITURE 
Low Activity
Comorbidity 
Depression,  
 
Poor Self-rated health 
Disability 
Urinary 
Incontinence 
Figure 1.1 Adaptation of the Cycle of Frailty developed by Fried et al. (2001).  Frailty was operationalized as the 
presence of 3 out of 6 variables identified as indicators of functional decline in one of the three physiological systems at 
the core of the cycle of frailty.  Covariates are shown with known relationships to frailty. 
7validity for the phenotype for frailty as defined by Fried et al. (2001) was established by applying 
it to different populations in similar settings, and in different settings with similar populations 
(Bandeen-Roche et al., 2006; Newman et al. 2001; Woods, et al. 2005) and obtaining comparable 
results. 
Overview of Research on Frailty 
As interest in the phenomenon of frailty has grown, researchers have sought to improve 
early detection methods used to screen for frailty (Hammerman, 1999).  Conceptual models have 
been proposed by medical, physical, behavioral, and social scientists (Markle-Reid et al., 2005) 
in an effort to explain and define frailty.  Although these screening tools and conceptual models 
have not been able to adequately explain all aspects of frailty, they have helped to bring frailty 
into better focus.  While a universal definition for frailty has yet to be determined, frailty experts 
generally agree that frailty involves: (a) a state of increased vulnerability to adverse health 
outcomes, and b) depletion of reserve function across multiple functional domains.        
Screening tools for frailty are intended to guide healthcare professionals in their 
assessment of older adults.  These include those tools that predict which older adults are most 
likely to fall (Speechley & Tinetti, 1992), predict adverse health outcomes (Fried et al., 2001; 
Lachs et al., 1990), or classify frailty in terms of severity (Rockwood, Stadnyk, MacNight 
McDowell, Hebert, & Hogan, 1999; Rockwood et al., 2006).  The development process for each 
of these tools has increased the knowledge and understanding of frailty and helped to identify it 
as separate from disability or comorbidity, commonly used as synonyms for each other. 
Frailty is considered to be a multidimensional phenomenon, yet the specification of 
number and type of dimensions necessary to determine frailty has yet to be determined.  
Therefore, the number of frailty criteria as well as the number of functional domains represented 
can vary from tool to tool and model to model.  Most tools include some measure of physical or 
8physiological function (Lachs et al., 1990; Rockwood et al., 1999, 2006; Speechley and Tinetti, 
1992; Woods et al., 2005).  Some tools include measures of psychological and social dimensions 
as well (Lachs et al.; Speechley & Tinetti), while others include measures of urinary incontinence 
(Lachs et al.; Rockwood et al., 1999, 2006), changes in cognition (Lachs et al.; Speechley & 
Tinetti, et al.; Rockwood et al., 1999, 2006), and ability to function independently (Lachs et al.; 
Rockwood et al., 1999, 2006).  For some tools, frailty is determined by measuring functional 
status (Lachs et al.; Rockwood et al., 1999, 2006) while other tools are meant to predict adverse 
health outcomes commonly associated with frailty (Speechley & Tinetti; Fried et al.; Woods et 
al.).   
Inconsistency in measures of frailty makes it difficult to compare study results. For 
example, Speechely and Tinetti (1992) determined that 20% of their study population was frail 
when frailty was defined by 13 criteria across five functional domains (sociodemographic, 
psychological, health behaviors, metabolic, and physical performance). While Fried et al. (2001) 
found seven percent of their study population to be frail when frailty was defined by five 
indicators  of the depletion of physiologic reserves (loss of lean body mass, weak grip strength, 
report of exhaustion, slowed walking speed, measure of low activity) and found to predict 
outcomes associated with frailty.   In both instances, a minimum number of criteria needed to be 
met for frailty to be measured but without a standardized definition, it is unclear whether one 
study may have overestimated or the other underestimated the prevalence of frailty.     
Fried and colleagues (2001) determined that participants who met three or more of the 
criteria for frailty (listed above) at baseline were significantly more likely to experience adverse 
health outcomes associated with frailty (e.g. prolonged hospitalization, slowed recovery, new or 
worsened disability, discharge to nursing home, falls, death) than those who met only one or two 
frailty criteria at baseline.  Furthermore, they demonstrated that, even though the domains 
overlap, frailty is distinct from disability and comorbidity.  Both sex and race were reported as 
9sample characteristics but not compared in terms of variance in frailty.  Identifying sex and racial 
differences in frailty is important to determine whether tailored interventions are needed for men 
and women of various races. 
Some conceptual models of frailty have used a linear approach to explain relationships 
between risk factors, performance, and outcomes.  Models based in medical science are centered 
on the physiological characteristics of frailty.  For example, Buchner and Wagner (1992) 
developed a systems model that depicts frailty as decreased capacity in three physiological 
systems (neurological, musculoskeletal, and energy metabolism).  In this model, the state of 
decreased physiological capacity is the result of the effects of biological aging, accumulation of 
chronic conditions, or disuse/abuse and frailty leads to disability by means of declines in physical 
performance and progressive social isolation.   
Bortz (1993), on the other hand, uses principles of physics to demonstrate the relationship 
between the human organism and the environment which requires a balance between use and 
disuse for the organism to thrive.  Bortz argued that too little stimulus is just as damaging as too 
much, and a combination of the three elements - disease, disuse, and aging - leads to frailty.  He 
further denotes that frailty is brought on by age-related molecular changes, genetic variation, and 
chronic illness that affect the capacity of the organism to respond to environmental change or 
stress, and result in an interaction between neuroendocrine dysregulation and low grade 
inflammation that leads to sarcopenia and hematological changes (Bortz, 1993).    
The Cycle of Frailty is consistent with both of these models.  The three entry points into 
the Cycle of Frailty are comparable to Buchner and Wagner’s three critical physiological 
systems.  While antecedents to the Cycle of Frailty reflect the antecedents identified by Bortz, 
and the outcomes of malnutrition and sarcopenia are consistent with outcomes of neuroendocrine 
dysregulation, low grade inflammation, sarcopenia and hematological change identified by Bortz.  
10
Heart Failure and Frailty 
 From data acquired during the Cardiovascular Health Study (CHS), Fried et al. (2001) 
found cardiovascular disease to be among the three most common chronic illnesses present at 
baseline in subjects who fit their definition for frailty.  Applying the same definition as Fried, 
Newman et al. (2001) examined the relationship between clinical and subclinical cardiovascular 
disease and frailty in CHS participants. Using a sample of 4,735 from the CHS population of 
5,288 adults aged 65 and older, they found a significant (p <.05) relationship between individual 
measures of cardiovascular disease and frailty.  More importantly, they determined that those 
who were frail were nearly eight times more likely to have HF than those who were not frail.    
Using a slightly different measure of frailty, the Frailty Staging System (FSS), Cacciatore 
et al. (2005) studied a sample of 1780 community dwelling Italians with and without HF over 12 
years.   The FSS is based on a complex definition of frailty that includes criteria from seven 
domains (disability, mobility, cognitive function, visual function, hearing function, urinary 
continence, and social support).    Frailty was found to decrease survival both with and without 
HF when compared those without frailty.  The probability of survival beyond nine years 
decreased dramatically as frailty level increased.  These results raise more questions regarding 
the relationship between frailty and HF and more research is warranted. 
Frailty and Sex and Race 
Differences found in risk factors or antecedents, clinical characteristics, and short-term 
(30 days) as well as long-term (nine years) survival after onset of HF are significant for men and 
women (Ho et al, 1993).  For example, early research by Ho and colleagues (1993) determined 
that women with HF have better long-term survival rates after the onset of HF than men with HF.  
They also determined that the cause of HF in women was most likely valvular heart disease, 
while the cause of HF in men is most likely coronary artery disease.  Failure to recognize these 
11
differences in cause and progression of HF for men and women contributed to the under-
diagnosis and under-treatment of HF in women for many years (Ho, et al., 1993).  While 
significant differences in HF related to sex and race have been identified, little work has been 
done regarding sex- or race-related differences in frailty.   
A finding of sex- or race-related difference in the association of individual frailty markers 
to mortality, or other adverse health outcomes associated with frailty, may be an indicator that 
different pathways lead to frailty. Puts et al. (2005) found differences in mortality rate, relative 
risk for individual frailty markers, and total number of frailty markers between men and women.  
Other studies have linked frailty to increased mortality (Mitnitski et al., 2002) and, when sex was 
considered, found that frail men died sooner than frail women of similar age at onset (Rockwood 
et al, 2006).   Because an increased mortality rate has been found in those with both HF and 
frailty, it is important to study frailty in HF patients so that interventions for HF targeted to the 
needs of the frail, or potentially frail, older adult can be developed. The findings that males and 
females differ in number and type of frailty markers, and that males have been found to die 
within a shorter period of time than females, suggest that frailty affects men and women 
differently.  Therefore, sex should be considered when exploring frailty in the presence of HF. 
Race may also be a factor in HF and frailty.  HF is more prevalent in Black men and 
women and Mexican-American men than White men and women (American Heart Association, 
2006). Because 75% of those diagnosed with HF have prior hypertension, racial differences in 
this group may be related to the higher prevalence of hypertension in Black adults.  In a study to 
examine the association of race with frailty, Hirsh et al. (2005) found that in participants of the 
CHS, a greater proportion of Black women (15%) had frailty compared to Black men (8.7%).  
Furthermore, frailty was present in a greater proportion of both Black men and Black women 
subjects than either White men (4.6%) or White women (6.8%).  In fact, when controlling for 
age, sex, comorbidity, and socioeconomic status, Blacks were four times more likely to be frail 
12
compared to Whites. Therefore, when examining frailty in the presence of HF, race should also 
be examined.  This information may assist in developing interventions to reduce the disparity of 
frailty in those of Black race. 
Summary 
Caution must be used when comparing research findings related to frailty, because there 
is, as yet, no universal definition for the concept (Anderson & Johnson, 1996; Fried et al., 2001; 
Walston et al., 2006).  A spiraling decline in functional reserves needed to withstand 
environmental demands such as illness, loss, or relocation results in adverse health outcomes 
(e.g. loss of physical strength and independence when hospitalized, a need for assistance with 
even the basic everyday functions, admission to a long-term care facility, prolonged period of 
disability, or premature death) commonly associated with frailty. The progressive activity 
intolerance and subsequent activity limitations experienced by HF patients and designated by 
NYHA Class III and IV are known risk factors for frailty (Bortz, 1993; Buchner & Wagner, 
1992) which may explain why HF patients are at increased risk of developing frailty.  Frailty 
increases mortality risk in HF patients (Newman et al., 2001), therefore HF patients who are frail 
have a poorer prognosis than those who are not frail. Without understanding the influence of sex 
or race on differences in frailty characteristics, or the importance of sex or race to relationships 
between frailty and risk factors and adverse health outcomes, a significant number of those with 
frailty may be overlooked and measures to improve outcomes, quality of care and life for these 
patients (Puts, Lips, & Deeg, 2005) may be less effective.  
Research Design and Methods 
An exploratory study using a descriptive correlational design was conducted by 
secondary analysis of data from the study of Urinary Incontinence and Overactive Bladder in 
Heart Failure Patients (UI/OAB-HF).  The Cycle of Frailty provided the conceptual framework 
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that guided variable selection, and objective indicators of chronic undernutrition, energy 
deficiency, and reduced energy expenditure were identified within the available database.  Frailty 
was defined as the presence of three or more of the following indicators:  a) Body Mass Index 
(BMI) <18.5 kg/m2 or BMI>30 kg/m2; b) Hemoglobin (Hgb) <12.5 g/dl for women, or <13.5 
g/dl for men; c) Albumin <3.8 g/dl;  d) Iowa Fatigue Scale (IFS) score>35; and e) Ejection 
Fraction (EF) < 40% or NYHA Class III or IV heart failure.    
Specific Aims 
1. Determine prevalence of frailty in UI/OAB-HF participants, and determine whether 
prevalence differs by sex or race. 
2. Identify frequency of individual frailty characteristics in UI/OAB-HF participants, 
and determine whether frequency differs by sex or race. 
3. Identify frequency of unique combinations of frailty characteristics observed among 
the UI/OAB-HF participants, and determine whether combinations differ by sex or 
race. 
4. Examine relationships between frailty and depression, help with IADLS, self-rated 
health, urinary incontinence, and comorbidity in UI/OAB-HF participants, and 
determine whether relationships differ by sex or race.  
 
CHAPTER II 
REVIEW OF LITERATURE 
 
The preceding chapter introduced the issues related to the concept of frailty, described the 
significance of the study of frailty for meeting the future healthcare needs of older adults, and 
gave a brief overview of the research to date on frailty.  This chapter is a review of the literature 
surrounding the topics introduced in chapter one.  The following review will begin with a 
discussion of the Cycle of Frailty, the conceptual framework for this study.  Next it will continue 
with an examination of literature representative of the current understanding of frailty beginning 
with progress made by experts to reach consensus regarding a definition of frailty, conceptual 
models that explain different aspects of the nature of frailty, screening tools that identify the 
characteristics of frailty, research that demonstrates an association between HF and frailty, and 
research to date on gender differences in frailty.   
Conceptual Framework 
 Fried and colleagues (2001) hypothesized that human frailty is a complex syndrome 
resulting from a cycle of physiological decline in which the older adult becomes increasingly 
vulnerable to adverse health outcomes (Fried et al., 2001; Walston, 2005).  They proposed that 
the core of this cycle revolves around declines in skeletal muscle mass (sarcopenia), energy 
expenditure (hypometabolism), and neuroendocrine regulation (chronic undernutrition). An 
individual can begin the cycle at any point, with a change in one 
17
functional domain affecting a change in the next one.  For example, an individual experiencing 
chronic undernutrition  will eventually begin to lose muscle mass which leads to loss of strength 
and power, thus decreasing activity level, which leads to reduced energy expenditure and reduced 
energy demand leads to further appetite is suppression followed by even more decline in strength 
and power.  They tested their model with participants in the Cardiovascular Health Study (CHS) 
(Fried et al., 2001).   
Original participants in the CHS were recruited from HCFA Medicare eligibility lists in 
four counties from different parts of the country in 1989-1990, with an additional cohort of 
African Americans recruited in 1992-1993.  Baseline data included standardized interviews, 
standardized performance-based measures, fasting blood studies, and various diagnostic tests.  
Standardized algorithms were used to review results from diagnostic tests, examinations, and 
chart review, to validate the presence of diseases reported by participants (Fried et al., 2001).    
From the participants in the CHS, 5,317 were found who met the inclusion criteria and 
were not missing any data relevant to the frailty phenotype, not taking Sinemet, Aricept, or 
antidepressants, with a Mini-Mental score >18, and without a history of Parkinson’s disease.  
Frailty characteristics were measured at baseline, at three, and at seven years for the first cohort, 
and at baseline (the third year of the original study) and four years later (the fourth year of the 
original study) for the second cohort.   Construct validity of the phenotype was determined by the 
ability of frailty criteria to predict the incidence of adverse health outcomes (first hospitalization, 
first fall, worsening dependency with ADLs or new disability, and worsening mobility or death) 
from baseline to the three- and seven-year follow-up for the first cohort, and four-year follow-up 
for the second cohort. They found a significantly higher incidence of all outcome measures at 
both the 3 year and 7 year assessment periods in the frail group of the first cohort when compared 
to the intermediate and not-frail groups.   They also were able to show that, while the domains of 
disability, comorbidity, and frailty do overlap, frailty is a distinct syndrome with nearly 27% 
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reported to have no disability and no more than one chronic illness (Fried et al., 2001). These 
findings provide evidence that the frailty phenotype is measurable, distinguishable from 
disability and comborbidity, and that the criteria for frailty measure what they are supposed to 
measure and support the premise that frailty is a complex syndrome. 
Woods and colleagues (2005) replicated findings of the CHS with data from the Women’s 
Health Initiative Observational Study (WHI-OS).  In the WHI-OS, data are drawn from 
postmenopausal women, 65-79 at baseline, who were recruited from 40 clinical centers across the 
United States.  Unlike data collection in the CHS, these data were collected using standardized 
questionnaires plus examination data.  Characteristics of the frailty phenotype were 
operationalized using two subscales from a standardized physical function scale (Rand-36), 
calculated Kcal of energy expended over the past week, and calculated BMI with self-report of 
unintentional weight loss.  They found that women who met the criteria for frailty at baseline 
were more likely to have ADL disability (5.9%) than non-frail women at baseline (0.7%), 78% of 
those who were frail reported > 2 comorbid conditions, and 23% reported < 2 diseases, while 
only 6% reported ADL disability.  These data are comparable to the CHS findings of 68%, 32%, 
and 27% respectively.  It is interesting to note that while 94% of the frail women in the WHI-OS 
reported no ADL disability, and 72.8% of frail participants in the CHS reported the same, both 
groups were at greater risk for adverse health outcomes than non-frail participants. In addition, 
Woods and colleagues found that over an average of 6 years, frail women were 3.15 times more 
likely to develop ADL disability, and 1.96 times as likely to be hospitalized, 1.57 times as likely 
to experience a hip fracture, and 1.71 times as likely to die .  These findings are consistent with 
the combined hazard ratios in the CHS which were 3.15 for worsening mobility and ADL 
disability, 1.27 for hospitalization, 1.23 for falls, and 1.63 for death.   
Bandeen-Roche and colleagues (2006) also replicated CHS findings using data from the 
Women’s Health and Aging Studies (WHAS I and II). These data were collected using nearly 
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identical measures for frailty as the CHS.  Participants in WHAS I represented one third of the 
most disabled community-dwelling women (n=1002), while in WHAS II they represented two 
thirds of the least disabled community-dwelling women (n=436).  To evaluate construct validity, 
they used latent class analysis to look for patterns that would establish frailty as a syndrome, i.e. 
that a critical mass of criteria needed to be present, and that the criteria occurred in a certain 
order.  First they found that the model fit the data, a good fit between predicted and observed 
frequencies when either a two-class (frail, non-frail) or three-class model (non-frail, intermediate, 
frail) were used (W2 p = .22 and .52).  When the mean number of criteria needed to manifest 
frailty was calculated, the three-class model findings of 1.26 for the second (intermediate) class, 
and 3.42 for the third (frail) class matched the CHS definition of 1-2 criteria for intermediate and 
> 3 criteria for frail.  Data collected every 18 months over three years were used to determine 
hazard ratios for frailty for severe ADL disability 15.79, severe IADL disability 10.44, 
hospitalization 0.67, falls 1.18, permanent nursing home entry 23.98, and death 6.03.  These 
findings are consistent with the CHS findings in predicting adverse health outcomes associated 
with frailty. 
All three of these studies serve to establish the validity of the frailty phenotype by 
replicating the findings of the first study using different populations, and/or different measures of 
the criteria to establish that this construct of frailty is generalizable and has both criterion and 
construct validity.  Both the CHS and WHAS used standardized interviews to measure 
exhaustion and low energy expenditure, physical function tests to measure weakness and 
slowness, and direct measurement of changes in weight (Bandeen-Roche, et al. 2006; Fried et al., 
2001).  The WHI-OS used standardized questionnaires to measure slowness/weakness (Rand-36 
physical function scale), poor endurance/exhaustion (Rand-36 vitality scale and four items from 
the CES-D scale), physical activity (detailed physical activity questionnaire) and measurement of 
weight with self-report of unintentional weight loss (Woods, et al., 2005).  Data from all three 
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studies (CHS, WHI-OS, WHAS) supported construct validity of the frailty phenotype in that 
when >3 criteria were present, participants were at greatest risk for adverse outcomes associated 
with frailty (falls, increased ADL disability, increased IADL disability, hospitalization, 
admission to nursing home, or death), and when 1 or 2 criteria were present, those participants 
were at greater risk than those with no criteria present suggesting that there is an intermediate or 
transitional stage of frailty.     
Research to Date 
Defining Frailty 
Without a precise scientific definition it has been difficult to determine prevalence of 
frailty in the population of older adults living in the community.  Disability is often used 
synonymously with frailty in older adults and is the basis for estimates by The Urban Institute 
that almost 27% of adults 65 and older, living in the community, are frail (Johnson & Wiener, 
2006).  Of those who are frail, it is estimated that 80% have three or more disabilities that require 
help with basic personal care (ADL) or limit independence (IADL), and 6% are severely disabled 
(Johnson & Wiener).  The prevalence here may be an overestimate, as frailty in this report is 
defined as “having some type of disability that limits their ability to perform basic personal 
activities or live independently” (Johnson & Wiener, p. 3).   
A definition that captures the essential nature of frailty has been elusive because (a) 
frailty does not have a tangible form that is easily measured (Rockwood, 2006), (b) it involves 
complex physiological systems, and (c) it shares common features with disability and 
comorbidity (Fried et al., 2001; Walston, 2005).  To complicate matters further, many indicators 
of frailty, such as changes in walking speed, vision, hearing, cognition, or physical strength, can 
be mistaken for normal consequences of aging and may not be reported by older adults and their 
families during a standard history and physical (Higby, 2001; Matteson & McConnell, 1988) or, 
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if they are reported, the significance of these indicators is not recognized by the clinician (Lachs 
et al., 1990).  Yet, it is precisely these changes that harbinger the “cascade to dependency” 
(Creditor, 1993, p. 22) that is often brought on with hospitalization. 
The use of the term frailty by gerontologists rose from a need to describe a subpopulation 
of patients >65 years of age who were most vulnerable to adverse outcomes when hospitalized 
(Hogan, MacKnight, & Bergman, 2003).  More than two decades ago frail elders were described 
by Robison (1981) as those “who have reached a great age, in excess of 75, and who have during 
their long life accumulated multiple disabilities and/or chronic illnesses” (p. 423).  In her practice 
as a gerontological nurse practitioner, Robison found that older patients, who fit this description, 
quickly decompensate in the presence of illness and injury, and if they do not succumb, the 
recovery phase is usually prolonged and difficult.  Experts in geriatric care, like Robison, are able 
to recognize frailty intuitively, based on years of experience.  Even so, with this definition frailty 
is most likely to be identified in the later stages when a choice between palliative care versus 
aggressive therapy is being made.  
A little more than a decade ago, Anderson and Johnson (1996) applied a definition of 
frailty that began to explain the outcomes described above.  They defined frailty as “a clinical 
syndrome. . . [that] refers to delicate individuals who lack resiliency” (para. 12) and have 
sustained significant functional losses across three physiological domains: neurological, 
musculoskeletal, and energy metabolism. They used a case study to illustrate the association 
between frailty and functional loss by describing the indicators of depleted reserves, brought on 
by a recent loss.  In this study an 81 year old woman, recently widowed, experienced subtle 
declines in physiologic reserves involving several organ systems over a relatively short period of 
time.  When she fell and broke her hip she experienced a complicated recovery from surgical 
repair of the hip resulting in her being discharged to a nursing home rather than returning home 
to live independently.  In their example, the patient experienced losses in the psychosocial 
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domain that led to depressed mood and lower self-esteem, decreased physical strength and 
exhaustion, and poor appetite with unintentional weight loss of 15 pounds.  These changes 
occurred gradually and she was able to remain independent until she broke her hip by adapting 
her daily routine to compensate for her changes in mood and energy since her husband’s death. 
However, at the time of her fall, she had lost weight, lost strength, was less active, and less 
socially connected, leaving her with inadequate resources needed for a swift and uneventful 
recovery.  
Anderson and Johnson’s description of one woman’s loss of independence as a result of a 
significant emotional loss is consistent with the current understanding of frailty as a complex 
geriatric syndrome that involves failing functional reserves across multiple domains.  In this case 
the catalyst was a fall, but it could as easily have been relocating and having to adapt to a 
different culture or neighborhood.   
Screening Tools and Models 
 Screening tools. As a rule, screening tools are intended to be quick and easy, and should 
be able to identify those who need a follow-up, in-depth assessment or immediate attention.  
Believing that functional limitation is often more of a concern than managing chronic illness in 
older adults, Lachs, et al. (1990) developed a screening tool that was intended to be short, easy 
and inexpensive to use, which would guide primary care providers in targeting specific areas of 
functional decline in elderly patients.  However, their tool is actually more of a guide that lists 
direct observations of task performance that by consensus were determined to be more reliable 
predictors of functional decline than self-report (Lachs et al.).  This tool is notable in that it 
encompasses more than physical ability and includes assessment of nutritional, mental and 
psychosocial aspects of functional status as well.  While Lachs and colleagues do not define 
frailty per se, their instrument does provide an opportunity for patterns of frailty characteristics to 
be observed in asymptomatic older adults.  
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In the process of studying the phenomenon of falling in the elderly, Speechley & Tinetti 
(1992) developed a scale that separated participants into three functional groups: vigorous, frail, 
and transitioning to frailty.  Data from 336 participants (enrolled from an eligible subset of 1762 
potential subjects who were more than 75 years old and participants in the Yale Health and 
Aging Study), were obtained by administering standardized tests of mental status (Short Portable 
Mental Status Questionnaire -- [SPMSQ]), emotional status (Center of Epidemiological Studies 
Depression scale  [CES-D]), vision or hearing impairment, functional disability (determined by 
means of physical measures of strength and balance, or needing help with ADLs or IADLs), 
BMI, and sedative use.  Using Principal Components Analysis, Speechley and Tinetti identified 
one component that they called frail with 9 factors and a second factor called vigor with four 
factors.  They developed a rule-based definition of frailty as having at least four “frail” attributes 
and no more than one “vigor” attribute present simultaneously. Vigorous was defined as three or 
more “vigor” attributes and no more than two “frail” attributes present simultaneously. Persons 
who fell in between the two extremes were designated as the transitional group. Vigorous 
subjects were less likely to fall, most likely to fall somewhere other than home, and more likely 
to sustain a greater injury from a fall.  Frail subjects were more likely to fall, most likely to fall at 
home, and less likely to sustain a major injury from the fall.  
As did Lachs et al. (1990) above, Speechley and Tinetti (1992) chose to assess more than 
physical symptoms and drew criteria from multiple domains (sociodemographic, psychological 
functioning, health behaviors, medications, and physical symptoms) to use as targets for 
determining functional status.  Their tool was aimed at predicting older adults most likely to fall 
or experience adverse health outcomes, and provided a place to begin when developing models to 
explain the mechanisms involved in both the development and progression of frailty (Bortz, 
1993; Buchner &Wagner, 1992; Fried, 1999).  
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Rockwood, Stadnyk, MacNight McDowell, Hebert, and Hogan (1999) developed a frailty 
index so that they could predict those most likely to experience adverse health outcomes, need 
for long-term care (LTC), or death.  Unlike Speechley and Tinetti, who based their definition on 
the number of individual characteristics present, Rockwood and colleagues use indicators of 
progressive decline in physical function, worsening of symptoms, and progressive dependence on 
others to represent each level of frailty (from 1 to 3). When they tested their frailty index, they 
found that the higher the level of frailty, the higher the risk of institutionalization or death.  
Specifically, they found the relative risk for admission to LTC for those at level one to be 1.7 
(95% CI 1.3-2.1), level two was 3.6 (3.1-4.3), and level 3 was 9.4 (7.7-11.5).  The relative risk 
for death was 1.2 (1.0-1.2), 2.0 (1.8-2.2), and 3.1 (2.7-3.8) respectively.   
Fried and colleagues (2001) define frailty as a clinical syndrome of increased 
vulnerability to adverse health outcomes, in which multiple biological systems have depleted 
physiological reserves to a point that it is difficult for the human organism to respond adaptively 
to environmental changes (e.g. injury, loss, relocation).  They have presented evidence of a 
phenotype for frailty that is determined when three or more criteria are met.  While testing their 
hypothesis that frailty is a cycle of declining energetics (see discussion on conceptual model, 
page 5) they found the following five parameters to be particularly good at predicting health 
outcomes attributed to frailty: sarcopenia (loss of skeletal muscle mass) or more than 10 pounds 
of unintentional weight loss over past year as a result of nutritional deficits, weakness, slowness, 
exhaustion, and low activity.   
Models. Conceptual models are representations of theoretical relationships between 
elements of a phenomenon that offer explanations for complex phenomenon.  Using a systems 
approach for their model, Buchner and Wagner (1992) proposed that frailty involves a loss of 
capacity of the organism to respond to stress, leading to failure of major organs and resulting in 
declines in physical performance and progressive social isolation (Buchner & Wagner). Buchner 
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and Wagner focused on three physiologic dimensions in their model: neurologic control, 
mechanical performance, and energy metabolism.  For Bortz, (2002) a combination of three 
elements leads to frailty, disease, disuse, and aging. Combining these explanations Fried and 
Walston (1998) considered disease, disuse, and aging to be pathways to frailty and hypothesized 
a model of frailty based on the three physiologic dimensions: neuroendocrine dysregulation, 
sarcopenia, and immune dysfunction.   
In Buchner & Wagner’s explanation, frailty is associated with reduced physiologic 
reserve that leads to increased susceptibility to disability.  Bortz (1993) used principles of physics 
to demonstrate the relationship between an organism and the environment that requires a balance 
between use and disuse for the organism to thrive.  Bortz argued that too little stimulus is just as 
damaging as too much, and a combination of three elements, disease, disuse, and aging, leads to 
frailty.  Since two of the three elements are potentially reversible, hypothetically decreasing 
incidence of frailty, or at least postponing the age of onset, should be possible. 
Heart Failure and Frailty 
From data acquired during the Cardiovascular Health Study (CHS), Fried et al. (2001) 
found cardiovascular disease to be among the three most common chronic illnesses present at 
baseline in subjects who met the criteria for frail.   Newman et al. (2001) examined the 
relationship between clinical and subclinical cardiovascular disease and frailty in CHS 
participants. In sample of 4,735 from the CHS population of 5,288 65 and older adults, they 
found a significant (p <.05) relationship between individual measures of cardiovascular disease 
and frailty.  Most importantly here, however, they determined that those who were frail were 
nearly eight times more likely to have chronic HF than those who were not frail.  Although it is 
clear that they found women more likely to be frail than men, they did not discuss those findings 
in any great detail.   
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Using a slightly different measure of frailty called the Frailty Staging System (FSS), 
Cacciatore et al. (2005) studied a sample of 1780 community dwelling Italians with and without 
CHF.  The FSS is based on a broad definition of frailty that includes criteria from seven 
functional domains (disability, mobility, cognitive function, visual function, hearing function, 
urinary continence, and social support).  Frailty was found to decrease survival both with and 
without CHF at 12 years.  The probability of survival beyond nine years decreased dramatically 
as frailty level increased.  The importance of learning more about frailty in HF patients cannot be 
underestimated. 
Differences by Sex and Race 
Differences found in risk factors or antecedents, clinical characteristics, and short-term 
(30 days) as well as long-term (nine years) survival after onset of HF are significant for men and 
women (Ho et al, 1993).  Ho and colleagues. (1993) determined that women with HF have better 
long-term survival rates after the onset of HF than men with HF.  They also determined that HF 
in women is most likely secondary to valvular heart disease, while HF in men is most likely 
secondary to coronary heart disease.  A lack of understanding of these differences in cause and 
progression of HF for men and women has contributed to the under-diagnosis and under-
treatment of HF in women for many years (Ho et al., 1993).   
While significant gender differences in HF have been identified, little work has been 
done regarding gender differences in frailty.  Puts, Lips, and Deeg (2005) found differences in 
mortality rate, relative risk for individual frailty markers, and total number of frailty markers 
between men and women.  Other studies have linked frailty to increased mortality (Mitnitski, 
Graham, Mogilner, et al., 2002), and found that men died sooner than women of similar age at 
onset (Rockwood, et al., 2006).  Finding differences related to sex in the association of individual 
frailty markers to mortality, or other adverse health outcomes, could be an indicator of different 
pathways to frailty.  One study investigated the effect of frailty on mortality in men and women 
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and found a significant association between frailty and mortality for both men (relative risk (RR) 
= 2.4) and women (RR = 2.6) (Puts et al., 2005).  When multiple chronic illnesses and disability 
were accounted for, the RR dropped to 1.6 and 2.0 respectively, indicating that the RR of 
mortality is higher for frail men in the presence of comorbidity, while the RR for women is 
higher in general.  Puts and colleagues also determined that women were frailer than men, though 
it is not clear whether this is based solely on the number of frailty characteristics present or 
another measure of vulnerability.  In spite of being less frail and the prevalence of frailty being 
almost half as high, men had a higher mortality rate during the follow-up period than women 
(Puts et al.). 
Race may also be a factor in HF and frailty.  Heart failure is more prevalent in Black men 
and women and Mexican-American men than White men and women (American Heart 
Association [AHA], 2006). Because 75% of HF diagnoses have prior hypertension, racial 
difference may be related to the high prevalence of hypertension in Black adults.  In a study to 
examine the association of race with frailty from participants of the CHS, Hirsh et al. (2005) 
found that a greater proportion of African American women (15%) had frailty compared to 
African American men (8.7%).  Likewise, a higher proportion of White women (6.8%) had 
frailty compared to White men (4.6%).  However, when controlling for age, sex, comorbidity, 
and socioeconomic status, African Americans were four times more likely to be frail compared to 
Whites. Therefore, when examining frailty in the presence of HF, race should also be examined.  
This information may assist in developing interventions to reduce the disparity of frailty in 
African Americans. 
Summary 
This chapter was a review of the research to date on frailty.  The Cycle of Frailty was 
presented as the conceptual framework for this study.  The discussion of the conceptual model is 
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followed by operational definitions for variables, a discussion of screening tools, models, HF and 
frailty, and differences by sex and race.  The next chapter describes the rationale for variable 
selection and analytic methods.  
CHAPTER III 
METHODS 
The research design, data source for secondary analysis, and an overview of the original 
study are discussed.  The process used for variable selection, and data analysis methods 
conducted over the course of the current study are also presented.     
Research Design 
Using a descriptive correlational design, a secondary analysis was conducted to examine 
differences between male and female, and Black and White hospitalized HF patients in terms of: 
a) the prevalence of frailty, b) the frequency of occurrence of specific frailty criteria, c) the 
frequency of occurrence of specific combinations of frailty criteria, and d) the relationships 
between frailty and depression, self-rated health, functional status, urinary incontinence, or 
comorbidity.  The purpose of this exploratory study therefore, was to examine frailty in HF 
patients and to describe the relationships between 1) frailty and sex, 2) frailty and race, and 3) the 
influence of sex and race on the relationships between frailty and depression, functional status, 
health status, comorbidity (more than two additional chronic illnesses), and urinary incontinence 
found in hospitalized HF patients.     
The Cycle of Frailty, described in detail in Chapter II, provided the conceptual 
framework for variable selection and analytic approach.   Specifically, this analysis sought to 
answer the following questions: 
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Research Questions 
1. What is the prevalence of frailty in UI/OAB-HF participants?  
a. Does prevalence differ for male and female subjects?  
b. Does prevalence differ for Black and White subjects? 
2. Do frailty characteristics observed in UI/OAB-HF patients differ in frequency between 
male and female, and/or Black and White subjects? 
3. Which unique combinations of the frailty characteristics are observable in UI/OAB-HF 
participants? 
a. Do combinations of characteristics differ in frequency for male and female 
subjects? 
b. Do combinations of characteristics differ in frequency for Black and White 
subjects? 
4. Are relationships observed between frailty and comorbidity, depression, help with 
IADLS, self-rated health, and urinary incontinence (UI) in UI/OAB-HF patients? 
a. Do these relationships differ for male and female subjects? 
b. Do these relationships differ for Black and White subjects? 
Frailty is a concept of particular interest to nursing as it is the result of declining 
functional reserves and impacts an individual’s ability to respond to changes in environmental 
demands adaptively.  While functional status in other domains, like cognitive or psychological 
function, social support, or socio-economic status, plays an important role, the focus of this study 
is on the bio-medical domain and indicators of declining physiological reserves.  The robust 
relationship found between HF and frailty (Newman et al., 2001), and indications that sex is 
associated with differences in the prevalence of HF (Ho et al, 1993), led to the current study of 
the association between sex or race and frailty in HF patients. 
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Data source 
The data source for this inquiry was the Urinary Incontinence and Overactive Bladder in 
Heart Failure (UI/OAB-HF) study; a study of factors related to urinary symptoms and HF.  
Access to the data source was granted by the principal investigator, Mary H. Palmer, PhD.  The 
original study, hereafter referred to as the parent study or UI/OAB-HF study was funded by a 
grant from Pfizer, Inc. Detrol Clinical Research Program in October 2005.     
The parent study was conducted at two outpatient HF clinics in a large urban area in the 
Southeastern U.S. and three in-patient units in one academic medical center in a mid-size city, 
also in the Southeastern US. Only data from the inpatient participants were used for the 
secondary analyses.  An overview of the parent study will be presented, including a description 
of the research design, sampling methods, and data collection procedures as they relate to the 
inpatient population.  This overview will be followed by description of the supplemental data 
collection procedures, variable selection process, instrumentation, and analytic methods used in 
this study. 
Overview of the Parent Study 
Design, Setting, and Sample 
Design. A cross-sectional survey design was used.  Data were collected using a 
standardized patient questionnaire and medical record review.  The sample consisted of patients 
admitted to an in-patient HF unit and 2 other medical units of a large academic medical center in 
the Southeastern US.  A representative number of women and African American subjects were 
included in the sample. The parent study obtained Institutional Review Board (IRB) approval.    
Setting. The academic medical center is a 703 bed, not-for-profit, public hospital.  The 
primary inpatient unit selected for data collection consisted of a 29-bed HF unit with telemetry 
plus eight transitional-care beds.  According to the Nursing Unit Director of the HF Unit, 
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approximately 220 patients with the single diagnosis of HF are admitted each year to the 
telemetry unit.  
Sample. Only patients with self-report of HF that could be confirmed by documentation 
in the patient’s medical record were eligible to participate in the parent study.  Additional 
inclusion criteria were: age greater than 20 years old, medical diagnosis or echocardiogram report 
of cardiomegaly, left ventricular hypertrophy, or ejection fraction <40%, alert and oriented as 
determined by the written nursing assessment in the medical record, and willingness and ability 
to participate.  Patients were excluded from the study if they had a chronic indwelling catheter or 
urostomy, were in renal failure, or on hemodialysis, because they were not at risk of urinary 
incontinence.  
Guided by the prevalence of HF in the United States population, a stratified sampling 
design was developed to reduce the effect of selection bias when using a convenience sample.  
The American Heart Association (2005) reports a prevalence rate for HF of 2.5% for white men, 
1.9% for white women, 3.1% for black men and 3.5% for black women.  In the latter half of the 
data collection period during a team meeting, it was projected that at the rate of enrollment at that 
time, the largest cell of the inpatient sampling frame, white males, would not be filled before the 
end of the study.  A decision was made to disregard the sampling design limits on black male, 
black female and white female patients and to enroll all eligible patients who were willing to 
participate, regardless of sex or race.  
Of the 275 in-patients invited to participate in the parent study, 70 declined (25%); 30 of 
them were male and 40 were female (11% and 15% respectively).  Reasons given for declining 
included: (a) being willing but too tired or too sick to answer so many questions, (b) visitors 
arrived, (c) not interested, and (d) not enough time before discharge to complete the 
questionnaire.   
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Nineteen records of the 205 patients enrolled were excluded from the database for the 
following reasons: a) two subjects declined completing the questionnaire because the wife of one 
enrolled subject, expressed concern that it was too soon after his procedure and felt that he 
needed to rest and a woman more than 80 years old decided she was not interested in answering 
any more questions after completing the first two pages of the questionnaire, (b) two were 
enrolled twice, (c) twelve gave contradictory responses on the questionnaire, and after closer 
inspection of data obtained from their medical records, and (d) three did not meet the inclusion 
criteria for the UI/OAB-HF study.  The remaining 186 hospitalized HF patients ranged in age 
from 20 years to 94 years of age, with a mean age of 61 years (SD=15).  While all subjects had 
been diagnosed with HF at some point, they were not all in acute failure at the time of the parent 
study.   
Instrumentation 
Demographic information included risk factors for urinary symptoms such as prostate 
enlargement or surgery for men or pregnancy and birth for women, medications prescribed for 
heart failure, needing help with instrumental activities of daily living (IADLS), clinical measures 
documented in the written medical record such as height and weight, blood pressure, age, sex, 
race, and marital status, and diagnostic history and labwork from the electronic medical record.   
Five well-established screening tools were included in the questionnaire for the parent 
study, International Consultation and Incontinence Questionnaire (ICIQ), Overactive Bladder 
questionnaire (OAB-q), Morisky Adherence Scale, Center for epidemiological Studies 
Depression Scale (CES-D), and Iowa Fatigue Scale (IFS).  Internal consistency was tested and 
Cronbach’s alpha >.95 for the three-component ICIQ (Avery, Donovan, Peters, Shaw, Gotoh, & 
Abrams, 2004), alpha =.96 for the eight-item OAB-q (Coyne, Revicki, Hunt, Corey, Stewart, 
Bentkover, & Abrams, 2002), and alpha=.61 for the four-item Morisky Adherence Scale 
(Morisky, Green, & Levine, 1998) were reported. Validity for the ICIQ was established by its 
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ability to distinguish between contrasting groups (Avery et al.). The OAB-q was shown to 
discriminate between patients with frequency, urge, stress and mixed incontinence (Coyne et al.).  
Sensitivity and specificity of the Morisky Adherence Scale were .81 and .44 respectively 
(Morisky et al.).  Psychometrics for the Center of Epidemiological Studies-Depression Scale 
(CES-D) and the Iowa Fatigue Scale (IFS) will be discussed with the instruments used in the 
current study.   
Protocols for In-patient Data Collection 
Sample selection. Following IRB approval, eligible patients were identified by trained 
research assistants from a review of the problem list of patients admitted to the HF center. The 
charts of the patients with a diagnosis of HF or cardiomegaly, and without a diagnosis of chronic 
renal failure in their problem list were reviewed further to determine whether patients were alert 
and oriented, without an indwelling catheter or urostomy, and not on hemodialysis.  After 
determining that the patient was eligible and consulting with the patient’s nurse, patients were 
approached and invited to participate in a study of urinary symptoms in HF patients.  When 
patients indicated the time was inconvenient, if they were asleep or otherwise indisposed, or if 
they were off the unit for a test, their invitation was deferred; they were to be approached at a 
later time, if possible.  Written informed consent was obtained prior to administration of the 
questionnaire and prior to collecting data from the patient’s medical record.   
Questionnaire administration. Potential participants were informed that they would 
receive a $10 incentive at the completion of the questionnaire.  The research assistant provided 
participants with a questionnaire, clipboard, pen, and answered any remaining questions about 
the study.  Completed questionnaires were collected within 30 minutes, examined for missing 
data, secured in a locked rolling file-case, and transferred to a locked file cabinet for storage in 
the Principal Investigator’s research office, devoid of personal identifiers.  Patients who provided 
written informed consent but were unable to read the questionnaire due to fatigue, poor eyesight, 
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and difficulty writing, were offered the opportunity to participate by having the questionnaire 
read aloud to them in a private space thus assuring confidentiality. 
Medical record review. Participant’s medical records were reviewed and data abstracted 
using a standardized tool by a trained research assistant.  The medical record review forms were 
handled securely by placing them in a locked rolling file when completed, then transferred to a 
locked file cabinet in the principal investigator’s office for storage.  No patient identifiers other 
than an ID number were used on these forms as well.  Data were double entered on an Excel 
spreadsheet and discrepancies in entry were completely resolved by retrieving the raw data 
collection forms.   
Current Study 
Protocols for Data Collection 
Data collection.  Because it was still possible to access the patient records of participants 
in the parent study, and because it was important to locate missing data and to obtain a complete 
diagnostic history; IRB approval was sought and obtained (IRB STUDY # 07-0159) to retrieve 
supplemental data from the patient’s electronic medical records.  Supplemental data were 
collected using a data-collection form designed to facilitate data retrieval as well as ensure 
accurate data entry. No personal identifiers were included on the data collection form.  
Redundant data (i.e. date of birth, admission date, and date diagnosed with HF) were collected to 
verify that supplemental data were entered on the right patient.  Diagnostic lab results were 
collected to reduce the number of missing data needed to define frailty (e.g. albumin, 
hemoglobin, and ejection fraction).  Clinical measurement data (height, weight, vital signs) were 
collected to confirm accuracy of data collected by research assistants for the parent study.  
Finally, a comprehensive diagnostic history was needed to be able to compute the Charlson 
Comorbidity Index (CCI).  Data were double entered and discrepancies were reconciled.  
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Data Storage. Completed supplemental data collection forms were handled securely and 
placed in a locked file cabinet in the office of the principal investigator for the parent study.  All 
original electronic data files were kept in password protected folders.  No electronic data files 
contain personal identifiers other than ID numbers.  No one other than the research team of the 
UI/OAB-HF study had access to the raw data.  Data were analyzed using version 9.1 of the SAS 
statistical software program.   
Instrumentation  
Descriptions of instruments used in the current study and their established reliability and 
validity are discussed:   
Comorbidity index. The Charlson Comorbidity Index (CCI) (Charlson, Pompei, Ales, & 
MacKenzie, 1987) was designed to estimate the risk of death from comorbid disease so that the 
potential for a subject to be lost to follow-up in longitudinal studies could be predicted. The CCI 
is an index of 19 major medical diagnoses with assigned weights from 1-6.  The higher the 
number assigned, the poorer the prognosis (Charlson et al.).  Prediction of more than 5-year 
mortality rates improved when one point of risk was added to the weighted comorbidity score for 
every decade of life after 40 years of age.  In fact, the age-comorbidity index achieved 100% 
accuracy in predicting 1-yr survival rates of the severely ill.  When actual survival rates were 
compared to 10-year survival rates predicted by the age-comorbidity weighted index, they were 
nearly identical (Charlson et al).  Support for construct validity was provided by testing 
convergence of the age-comorbidity index with the Kaplan Feinstein Method of predicting 
survival and finding that both scales produced similar survival curves (Charlson et al.). 
Depression scale. The Center for Epidemiologic Studies Depression Scale-Short Form 
(CES-D-SF) instrument included in the questionnaire is a well established screening tool for 
depression (Kohout, Berkman, Evans, & Corononi-Huntley, 1993).  The original CES-D contains 
20 items with a four-point response option.  It has consistently demonstrated high internal 
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consistency and reliability (Cronbach’s  > .80), and construct validity as an indicator of current 
depression has been tested with a range of populations, from physically and/or mentally well to 
physically and/or mentally ill and from young (early 20s) to old (late 70s) (Carpenter et al., 1998; 
Kohout et al.).  In one of the shorter versions of the CES-D the 20-items of the original scale 
were reduced to 10 with two-response options, known as the Boston 10X2 scale.  Carpenter and 
colleagues reported a Cronbach’s  coefficient of .84 for the shorter version, demonstrating that 
internal consistency and reliability were not lost.  Furthermore, when Kohut and colleagues 
compared the Boston 10X2 to the Yale 20X4 using principal components analysis with 
orthogonal varimax rotation, they found that the shorter version explained 61.1% of the variance 
while the longer test explained 46.5%, and that factor loadings for both scales were identical.  
The UI/OAB-HF questionnaire incorporated a short version of the CES-D published by 
The Stanford Patient Education and Research Center they call the “CES-D10” which is identical 
to the Boston version except that the CES-D 10 has four response options. A Chronbach’s alpha 
of .80 has been reported for this instrument by the Stanford group. The four response options 
were on a scale from “Rarely, or none of the time: less than one day” to “all of the time: 5-7 
days” in the context of the past week.  Items were weighted from zero to three; the higher the 
number the more often symptoms of depression occurred.  Response items “I felt hopeful about 
the future” and “I was happy” were weighted in reverse order to conceptually match the other 
eight items in the instrument.  However, instead of the cut-point of 10 used by the Stanford 
group, a cut-point of 14 was used to guard against false positives as suggested by Kohut et al.  
An alpha of .81 was found when the reliability coefficient was calculated for the CES-D 10 using 
UI/OAB-HF data.      
Fatigue scale. The Iowa Fatigue Scale (IFS) is a recently developed instrument (Hartz, 
Bentler, & Watson, 2002) intended for use when screening for fatigue in primary care patients.  
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The instrument is an 11-item scale with five response options on a scale from “not at all” to 
“extremely”.  The 11 items form four subscales identified by fatigue experts as most useful when 
screening for or monitoring fatigue: cognitive processing delay, feeling fatigued, lack of energy, 
and reduced productivity (Hartz et al.).  The subject was asked to choose the response that best 
described how he or she had felt over the past month.  Half of the items describe symptoms 
associated with fatigue, in which the higher the number the greater the statement reflects the 
patient’s experience; while the other half describe the absence of symptoms associated with 
fatigue.  These latter questions were reverse-coded when computing the fatigue score such that 
the lower the number the greater the statement reflects the patient’s experience.   
The IFS was derived from several existing fatigue instruments, from which items that 
detect the incidence of fatigue were retained and items that measure fatigue in terms of intensity 
or duration were excluded.  Internal consistency and homogeneity for the 11-item tool were 
supported by Cronbach’s Y =.90.  Comparison of contrasting groups was used as one test of 
construct validity.  Fifty-four to 66% of the group with the poorest health had scores greater than 
or equal to 40 on the IFS, indicative of extreme fatigue, while the group with the best health only 
had 5%-11% to get a score of 40 or above.  When convergent validity was tested by correlating 
results between the IFS and two other established measures of fatigue, correlations of r =0.95 and 
r =0.96 were found, indicating that the IFS was measuring the same thing (Hartz et al., 2002) 
though perhaps redundant.   
According to Hartz and colleagues (2002), one of the purposes for creating this 
instrument was to create a screening tool that required little time to complete, was effective yet 
easy to use.  Any item that was omitted by the test population was examined closely.  Only one 
item (“I have low output”) on the 11-item-tool was omitted by a small percentage (8%) of the test 
population; the other ten items were answered by everyone.  Hartz et al. suggested that while the 
tool was easy to understand overall, one of the questions was difficult for some people to 
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interpret.  Therefore, the questionable item was omitted from the questionnaire used for the 
UIOAB-HF study. Scoring was adjusted so that with the range of scores from 10-50 (originally 
10-55), the cut-off for extreme fatigue or exhaustion was indicated by a score of 35 or greater 
(originally 39 or greater).  The reliability coefficient calculated using data from the parent study 
and the 10-item instrument resulted in Chronbach’s alpha = .827. 
Variable Selection    
 Data for the parent study were collected at the time of enrollment, using both survey 
and medical record audit, and following IRB approval for the current study, by a second 
medical record audit.  Five covariates with known relationships to frailty were identified; 
depressed mood, self-report of poor health, UI, needed help with IADLs, and comorbidity).  
Variable selection of five measures for frailty characteristics needed to define frailty was 
guided by the conceptual framework (the Cycle of Frailty is described in detail in Chapter 2, 
and summarized here).  Fried and colleagues (2001) determined that there are three 
physiological systems at the core of the Cycle of Frailty: Chronic undernutrition and 
unintentional weight loss, sarcopenia and energy deficiency, and decreased energy 
expenditure and low activity (Fig. 3.1).  Frailty was operationalized in this study as the 
presence of three or more of five variables identified to serve as indicators of functional 
decline in these three systems. Those measures were then located within the cycle of frailty 
conceptually (Figure 3.1). Rationales for operational decisions follow:   
Chronic Undernutrition. Chronic undernutrition has been associated with unintentional 
weight loss (Fried et al., 2001).   One study used multiple measurements of weight to measure 
significant weight loss accurately (Fried et al.).  Others have used self-report of unintentional 
weight loss >5-10 lbs over the past two years to identify those at risk in this area (Woods et al., 
2005).  The data source for the present study did not collect repeated measures of weight or self- 
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Figure 3.1 Adaptation of the Cycle of Frailty developed by Fried et al. (2001).  Frailty is present when three or 
more criteria are met:  eObese=BMI >30 kg/m2; bUnderweight=BMI<18 kg/m2; cHypoalbuminemia=albumin 
<3.8g/dl; dExhaustion or severe fatigue =Iowa Fatigue Score > 35; eAnemia=HGB <13.5 g/dl if male, or 
<12.5g/dl if female; fLate heart failure=EF <40% or NYHA Class III or IV. 
report of weight loss.  It does contain a measure of height as well as a single measure of weight.  
Body mass index (BMI), calculated as a ratio of weight to height (kg/m2), is another clinical 
indicator associated with nutritional status (Newman et al., 2001; Bandeen-Roche et al., 2006).  
Standards for adult BMI ranges established by the World Health Organization (WHO, 2007), 
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were based on the effect of body weight on illness and disease, and include: underweight=BMI 
<18.5 kg/m2, and obese = BMI >30 kg/m2. Since a BMI below 18.5 kg/m2 has also been 
associated with frailty (Newman et al.) it was used as an indicator for chronic undernutrition in 
the current study.  
Serum albumin has been used in acute care settings as a clinical indicator of chronic 
undernutrition and severity of illness (Clochesy, Davidson, Piper-Caulkins, Carno, & Bauldoff, 
1999).  Hypoalbuminemia is an outcome of inadequate protein and caloric intake and suggests 
that protein stores may be at risk or depleted.  Corti & Guralnick (1994) determined that 
hypoalbuminemia correlates significantly with increased mortality risk.  Visser and colleagues 
(2005) found albumin levels less than 3.8 g/dl were associated with skeletal muscle loss; another 
indicator of frailty.  The cutoff of <3.8 g/dl was the measure chosen to indicate chronic depletion 
of protein stores and served as a second indicator for chronic undernutrition.   
Energy deficiency. Self-report of not having enough energy to accomplish a desired task 
has been shown to be a reliable method of discriminating between normal tiredness and 
exhaustion or severe fatigue; another characteristic of frailty (Fried et al., 2001; Bandeen-Roche 
et al., 2006; Woods et al., 2005). As described above, the Iowa Fatigue Scale (IFS) is a screening 
tool that uses a likert scale of 1-5 to measure the level of fatigue experienced.   With 10 items and 
five response options, scores ranged from10-50, and an IFS score that exceeded 35 was 
determined to indicate severe fatigue and a state of energy deficiency.   
Some have found an association between anemia and decreased physical performance 
and mobility (Chavez, Ashar, Guralnick, & Fried, 2002; Pennix, Guralnick, Onder, Ferrucci, 
Wallace, & Pahor, 2003.  Others have found anemia to be an independent predictor of muscle 
weakness (Pennix, Pahor, et al., 2004).  In the absence of direct measures of upper body and 
lower body power or strength, the presence of anemia (Hemoglobin <12.3 g/dl for women and 
<13.5 g/dl for men) provided a proxy for weakness. 
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Low Activity.   Decreased energy expenditure can be the result of reduced physical 
activity or it can refer to a slower metabolic rate (Buchner & Wagner, 1992).  The New York 
Heart Association (NYHA) functional classification of HF indicates progressively worsening 
ability to perform activities without significant distress (NYHA, 1994).  Class IV HF indicates a 
severe degree of disability where distress may be experienced at rest or with very minimal 
activity.  Class III HF is not so severe, but indicates that that distress is felt with the most basic 
activities, like moving from the bed to the chair (NYHA).  Likewise, an ejection fraction (EF) 
less than 40% indicates a significant loss of cardiac function needed to be active without distress.  
NYHA classification of Class III or IV, and/or EF <40% were used as a proxy for low activity.   
 Obese subjects have been found to have significantly slower walking speeds than people 
meeting the criteria for being overweight, or low normal weight (Blaum, Xue, Michelon, Semba, 
& Fried, 2005).  Blaum and colleagues found nearly half (47.4%) of those with a BMI > 30 
kg/m2 exhibited a significantly slower walking speed (p<.001) than those with a BMI >25 kg/m2
to < 30 kg/m2 (22.7%) or those with a BMI < 23 kg/m2 (17.5%).    
Villareal, Banks, Siener, Sinacore, & Klein (2004) found obesity to be associated with a 
significantly lower (p<.05) physical performance score (27.8 + 0.8) than non-obese (34.4 + 0.5), 
and a significantly (p<0.05) slower walking speed (74+ 2.9 m/min and 99.2 + 5.3 m/min 
respectively). Therefore, obesity (BMI >30 kg/m2) was used as a second indicator of low 
activity.  
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Table 3.1. 
Operational Definitions and Dummy Codes For Frailty Criteria  
Frailtya Characteristics  Criteriab Dummy Code 
Chronic under nutrition Albumun <3.8 g/dl 
BMI <18.5 kg/m2
Low Albumin, 0,1 
Underweight, 0,1
For men: Hemoglobin <13.5 g/dl Low HGB, 0,1 Energy Deficiency
For women: Hemoglobin <12.5 g/dl 
Iowa Fatigue Scale Score >35 Exhaustion, 0,1 
Low Activity Ejection Fraction <40% or  
NYHA Class III or IV HF 
Late HF, 0,1  
BMI > 30 kg/m2 Obesity, 0,1  
Note: aFrailty defined as when 3 or more frailty criteria are met.   bCut-off points by which criteria are either 
present=1 or absent=0.   
 
Table 3.2. 
Operational Definitions and Dummy Codes For Covariates 
Criteriab Dummy Code 
Covariatesa CES-D score >14 Depression, 0,1  
Self-report of urine leakage UI, 0,1  
Self-rated health as Poor Poor health, 0,1
Needs help with >1 IADL Disability, 0,1  
> 2 Chronic illnesses Comorbidity, 0,1   
Note: aIndependent variables with known associations with frailty.  bCut-off points by which criteria are either 
present=1 or absent=0.   
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Analytic Plan 
Statistical analyses were performed using exploratory statistical procedures.   Measures 
of central tendency (frequencies and percentages of categorical data and dispersion of continuous 
variables) were computed to describe the sample.  The Cochran-Mantel-Haenszel General 
Association statistical method (CMH) was determined to be  an appropriate method to examine 
associations between categorical explanatory and response variables when data were stratified by 
age group  (Stokes, Davis, & Koch, 2000). The Mantel-Haenzel 2 method was used for data that 
were not stratified.    Logistic regression modeling techniques were used to analyze the 
relationship between frailty and five explanatory variables, plus sex and race, while controlling 
for age (Polit, 1996).  Spearman’s rank correlation statistic was used to asses construct validity of 
the frailty construct used in this study. 
The first research question (RQ1), ‘What is the prevalence of frailty in UI/OAB-HF 
patients?’ was answered by calculating the proportion of subjects who met the criteria for frailty 
(the presence of three or more frailty characteristics).  Prevalence was determined for the total 
sample as well as by sex and by race. Significance of differences among subgroups was assessed 
using the Mantel-Haenzel 2 test (M-H 2).   
The second question (RQ2), ‘Do frailty characteristics observed in UI/OAB-HF patients 
differ in frequency between male and female, and/or Black and White subjects?’ was answered 
by first calculating frequencies for each frailty characteristic for the total sample and then by sex 
and by race.  Frequencies were then compared by sex, and by race by creating response-by-
explanatory-variables (r-by-s) contingency tables stratified by age group.  Significance was then 
tested using the Cochran-Mantel-Haenzel test of General Association (CMH).   
The third question (RQ3), ‘What combinations of frailty characteristics are observable in 
UI/OAB-HF patients?’ was answered by first determining the frequencies of each unique 
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combination of the six frailty characteristics (BMI is one indicator but represents two 
characteristics) for the total sample.  Frequencies were then compared by sex, and by race by 
creating r-by-s contingency tables.  These tables were not stratified at this point and tests of 
significance were not performed as too many row-totals were less than five.  Frequencies were 
then compared by sex, and by race by creating contingency tables stratified by number of 
characteristics combined (i.e. combinations of two, three, four, or five frailty characteristics).   
Significance was tested using the M-H 2.
Two levels of analysis were used to answer the fourth question (RQ4), ‘Are relationships 
observed in UI/OAB-HF participants between frailty and comorbidity, depression, disability, 
self-rated health, and urinary incontinence (UI)?’ For the first level of analysis, frequencies were 
determined for each of the preceding, five explanatory variables for the total sample.  Then 2-by-
2 contingency tables, stratified by age group, were created for each of variable by sex and by 
race.  Significance was tested using the CMH method and Odds Ratios (OR) were estimated. For 
the second level of analysis, logistic regression modeling was used.  Age group, race, and sex 
were included in all steps of the logistic regression procedures.    
Summary 
 This chapter began with a description of the research design for a secondary analysis of 
data.  The data source was a cross sectional cohort study that included an inpatient sample and an 
outpatient sample.  Only inpatient data were used in this study.  An overview of the data source, 
Urinary Incontinence and Overactive Bladder in Heart Failure Patients study, is followed by a 
description of instruments used to create the patient questionnaire, variable selection methods, 
and analysis plan.  The next chapter will report on the results of those analyses.  
 
CHAPTER IV 
RESULTS 
Frailty has been associated with increased vulnerability to adverse health outcomes in the 
presence of increased environmental demands such as illness, loss, or relocation, and is 
considered to be a geriatric syndrome by experts in gerontology, i.e. identified by a group of 
symptoms, (Bandeen-Roche et al. 2006; Fried, 1999).  This exploratory study examined 
differences in a) frailty and sex, b) frailty and race, and c) relationships between frailty and 
depression, functional status, health status, comorbidity, and urinary incontinence that occurred 
when age was held constant.  A secondary analysis was conducted on data collected from 
hospitalized chronic HF patients with permission from the principal investigator (PI) of the 
Urinary Incontinence and Overactive Bladder in Heart Failure (UI/OAB-HF) study.  This 
chapter describes the results of data analysis, beginning with sample characteristics, distribution 
of demographic variables, and clinical assessment variables, followed by a discussion of the 
results that address each research question (RQ).   
Sample Description 
Sample  
One hundred eighty-six records from the parent study were made available.  As the focus 
of the current study was on older adults, 32 records for subjects younger than 50 years old were 
excluded from analysis leaving a remainder of 154 subjects.  Middle aged (50-65 
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years) subjects were included here to reduce the potential for age bias as a result of the greater 
longevity of women and White race.     
Demographic Variables 
The sample divided equally into two age groups.  Seventy-seven subjects were between 
the ages of 50-64 years and 77 were between 65-94 years, overall mean age 66.18 (SD =10.76) 
years (Table 4.1).  Over half of the subjects were White (72%), male (58%), married (57%), 
 
Table 4.1.   
 
Sample characteristics: categorical variables  
 Demographics   N (%)a
Age group:
50-65 Years  77 (50)
>65 years  77 (50)
Sex
Male 90 (58)
Female  64 (42)
Race
Black 43 (28)
White  111 (72)
Marital Status
Married 88 (57)
Widowed/Divorced 60 (39)
Never Married 6 (4)
Table Continues 
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cont’d 
 Demographics  N (%)a
NYHA Class HFc
Class I 21 (15)
Class II    42 (30)
Class III 57 (41)
Class IV 19 (14)
Health Statusb
Excellent 6 (4)
Good 33 (21)
Fair 69 (45)
Poor  46 (30)
Urinary Incontinanced 78 (51)
Disabilitye 31 (20)
Frailty Status
Not Frail  96 (62)
Frail 58 (38)
Note: aN=154.  bHealth Status: range 1-4.   cN=139 because NYHA Class was 
not recorded in 15 medical records. 
and incontinent (51%) .  Unequal numbers of male to female and Black to White subjects were 
the result of sampling procedures for the parent study. Even though the majority of the study 
population was classified as having substantial activity restrictions due to HF, i.e. 55% were 
either Class III (41%) or Class IV (14%) less than a fourth of the sample reported needing help 
with IADLs (20%).  NYHA Class data were missing for 10% of the sample (N=154) despite the 
supplemental review of medical records completed for the current study.   Of those subjects who 
49
met the criteria for frailty (n=58), 59% were 65 years and older, 58% were female, and 69% were 
White (Table 4.2).  Male and female subjects  
 
Table 4.2. 
 
Categorical Demographic Variables for Hospitalized Heart Failure Patients 
Variables 
Not Frail 
n=96 
N (%)
Frail  
n =58 
N (%) 
Male 
n =90 
N (%)
Female 
n =64 
N (%) 
Black 
n =43 
N (%)
White 
n =111 
N (%)
Total 
N=154 
N (%)
Youngera 53 (55) 24 (41) 50  (56) 27 (42) 27(63)†† 50 (45) 77 (50)
Olderb 43 (45) 34 (59) 40  (44) 37 (58) 16 (37) 61 (55) †† 77 (50)
Male 65 (68) 25 (43) 90 (100) -- 23 (53) 67 (60) 90 (58)
Female 31 (32) 33 (57) -- 64 (100) 20 (47) 44 (40) 64 (42)
White 71 (74) 40 (69) 67  (74) 44 (69) -- 111 (100) 111 (72)
Black 25 (26) 18 (31) 23  (26) 20 (31) 43 (100) -- 43 (28)
Married 63 (66) 25 (43) 60 (67)† 28 (44) 20 (47) 68 (61) 88 (57)
Widow/ Divc 33 (34) 27 (47) 25  (28) 35 (55)† 20 (47) 40 (36) 60 (39)
Never Married -- 6 (6) 5 (6) 1 (1) 3 (7) 3 (3) 6 (4)
Note: aYounger=50 to 60 years. bOlder=>65 years of age. cWidow/Divor=Widowed or divorced. 
†Mantel-Haenszel W2 =4.0711, df=1, p=.04, test of significance of differences in marital status by sex; ††M-H W2 =3.8787, 
df=1, p=.05, test of significance of differences in age group by race. 
differed statistically by marital status (p=.04).  Sixty-seven percent of males were married, while 
55% of females were widowed or divorced.  A statistically significant (p=.05) difference was 
also found when comparing race by age group.  A greater proportion of Black subjects were 
between 50 and 65 years than Whites (63% vs. 45 %), while a higher proportion of White 
subjects were 65 years and older (55% vs. 37%) (Table 4.2).   
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Clinical Assessment Variables  
 Measures of central tendency (means and standard deviations) of interval level data were 
compared by sex and by race using the t-test procedure (Table 4.3).   The difference in mean age 
of female subjects at 68.10 years (SD=11.29) and the mean age of male subjects at 64.81 years 
(SD=10.22) neared statistical significance (p=.06) (Table 4.3).  Additionally, a statistically 
significant difference was found between mean BMI for female subjects compared to males 
(33.65 kg/m2 SD=13.8 and 29.6 kg/m2 SD=7.81 respectively, p=.03). Mean BMI for female 
subjects (BMI=33.86 kg/m2 ) exceeded the World Health Organization (WHO) minimum 
standard for Grade I obesity of BMI<29.99 kg/m2. While mean BMI for males was at the upper 
limit for overweight (BMI=29.6 kg/m2).  However, the BMI normalcy curve for female subjects 
was positively skewed (2.26) by three morbidly obese female subjects with BMIs between 50-90 
kg/m2 (see Table 4.3).  
 Male subjects, had poorer cardiac muscle function as indicated by ejection fractions (EF) 
that were significantly lower (p=.0005) than that of female subjects (mean=32.97 SD=18.012 for 
males, mean=43.67 SD=18.998 for females).  A bimodal dispersion curve of EF data for the 
sample was influenced by the greater proportion of female (47%) subjects with EFs > 50%, while 
the larger proportion of male (37%) subjects had EFs below 40%.   
Table 4.3.
Means and Standard Deviations (SD) for Clinical Assessment Variables and Covariates for Hospitalized Heart Failure Patients
Total Not Frail Frail Male Female Black White
M (SD) M (SD) M (SD) M (SD) M (SD) M (SD) M (SD)
Age (range 50-94 yrs) 66.18 (10.76) 65.69 (11.34) 67.00 (9.78) 64.81 (10.22) 68.10 (11.29)* 62.49 (9.55) 67.61 (10.9)†††
Systolic BP 129.78 (29.3) 128.56 (27.1) 131.83 (32.8) 126.27 (30.3) 134.83 (27.26) 133.79 (32.54) 128.24 (27.92)
Diastolic BP 72.83 (16.26) 73.41 (16.42) 71.88 (16.1) 74.73 (17.10) 70.11 (14.69) 77.12 (18.92) 71.15 (14.86)
MAPa 91.82 (18.34) 91.79 (17.94) 91.86 (19.15) 91.91 (19.79) 91.68 (16.20) 96.01 (20.38)* 90.18 (17.31)
BMIb 31.38 (10.87) 29.81 (11.45) 33.97 (9.37) 29.62 (7.81) 33.86 (13.79)† 31.65 (8.11) 31.28 (11.8)
Ejection fraction 37.41 (19.11) 39.06 (19.36) 34.69 (18.54) 32.98 (18.01)†† 43.66 (18.99) 31.84 (20.09) 39.58 (18.36)**
Hemoglobin 11.84 (2.202) 12.21 (2.37) 11.24 (1.74) 12.10 (2.45) 11.48 (1.74) 11.63 (1.81) 11.93 (2.34)
Albumin 2.32 (1.66) 3.55 (0.60) 3.272 (0.534) 3.44 (0.59) 3.34 (0.56) 3.42 (0.64) 3.39 (0.56)
IFS scorec 27.931 (6.93) 26.89 (6.86) 29.64 (6.76) 29.97 (6.56) 29.28 (7.26) 27.84 (7.19) 27.96 (6.86)
CES-D Scored 21.5 (6.40) 20.78 (6.30) 22.69 (6.45) 20.64 (6.09) 22.70 (6.68) 21.16 (6.70) 21.63 (6.31)
CCIe 4.95 (2.50) 3.32 (2.07) 4.95 (2.5) 3.64 (1.91) 4.34 (2.87) 3.81 (2.39) 3.98 (2.37)
Frailty scoref 2.62 (1.05) 1.64 (0.57) 3.41 (0.56) 1.93 (1.07) 2.85 (1.08) 2.65 (1.15) 2.19 (1.16)
Note: aMAP = Mean arterial pressure. bBMI=kg/m2. cIFS=Iowa Fatigue Scale; range 10-43. dCES-D=Depression Scale; range 0-27. eCCI=Charlson Comorbidity Index,
range 0-16. fFrailty Score, range 0-5.
*p=.04; **p=.02; † p=.03; ††p=.06; ††† p=.008.
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White subjects were older than Black subjects (68 years, SD=10.9 and 62 years, SD=9.5 
respectively) and differences in mean age were statistically significant at p=.008. (Table 4.3).  
Mean arterial pressure was significantly higher for Black subjects and demonstrated a wider 
range of variance (96.01 mmHg, SD=20.38 for Blacks, 90.18 mmHg, SD=17.31 for Whites, 
p=.04) (Table 4.3). 
Comorbidity 
 Comorbidities (the presence of two or more chronic illness in same individual at the same 
time) are of special concern when they occur with either HF or frailty because of the increased 
physiological demand on already stretched or limited physiological systems.  In this study, more 
than three-quarters of the sample (81%) had a diagnosis of hypertension (HTN), a known risk 
factor for HF. The majority of subjects with HTN were White, male, and not frail (70%, 56%, 
and 60% respectively).  A higher percentage of female subjects were diabetic (66%) or had some 
type of renal disease (53%).  Compared to the other chronic illnesses recorded, HTN (84%), 
diabetes (DM, 76%), and renal disease (76%) occurred in the highest percentage of frail subjects.  
Approximately one third of the patients were diagnosed with pulmonary disease (COPD), ulcer 
disease or myocardial infarction (MI) (34%, 32%, and 29%); and less than a fourth of the patients 
were diagnosed with osteo-arthritis (OA), cerebrovascular disease (CVD), or peripheral vascular 
disease (PVD) (23%, 23%, and 20%).  Medical diagnoses were similarly distributed among 
Black and White patients (Table 4.4).  Male and female subjects differed by less than a 10% in 
frequency of occurrence of additional chronic illnesses. 
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Table 4.4.   
 
Chronic Illnesses in Hospitalized Sample of Heart Failure Patients 
Total Not frail Frail  Male Female Black White 
Chronic Illness N=154 N=96 n=58 n=90 n=64 n=43 N=111 
(CCI weight )a N (%) N (%) N (%) N (%) N (%) N (%) N (%) 
HTNb (0) 125 (81) 76 (79) 49 (84) 72 (80) 53 (83) 37 (86) 88 (79) 
DMc (2) 86 (56) 42 (44) 44 (76) 44 (49) 42 (66) 61 (55) 25 (58) 
Renal Disease (1) 78 (51) 34 (35) 44 (76) 44 (49) 34 (53) 26 (60) 52 (47) 
COPDd (0) 53 (34) 34 (35) 19 (33) 33 (37) 20 (31) 11 (26) 42 (38) 
MIe (1) 45 (30) 31 (32) 14 (24) 31 (34) 14 (22) 10 (23) 35 (32) 
Ulcer Disease (1) 49 (32) 29 (30) 20 (34) 24 (27) 25 (39) 11 (26) 38 (34) 
Osteo-Arth  (0) 36 (23) 20 (21) 16 (28) 16 (18) 20 (31) 5 (12) 31 (28) 
CVDf (1) 36 (23) 19 (20) 17 (29) 18 (20) 18 (28) 7 (16) 29 (26) 
PVDg (1) 31 (20) 22 (23) 9 (16) 23 (26) 8 (13) 5 (12) 26 (23) 
Tumors (2) 23 (15) 15 (16) 8 (14) 10 (11) 13 (20) 4 (9) 19 (17) 
RA  (1) 8 (5) 5 (5) 3 (5) 2 (2) 6 (9) 2 (5) 6 (5) 
Liver Disease (1) 7 (5) 4 (4) 3 (5) 6 (7) 1 (2) 1 (2) 6 (5) 
Strokeh (2) 6 (6) 5 (5) 4 (7) 6 (7) 3 (5) 3 (7) 6 (5) 
Liver Failure (3) 7 (5) 5 (5) 2 (3) 4 (4) 3 (5) 1 (2) 6 (5) 
Lymphoma (2) 2 (1) 1 (1) 1 (2) 2 (2)          -- 1 (2) 1 (1) 
Metastasis (3) 2 (1) -- 2 (3)          -- 2 (3) 1 (2) 1 (1) 
Note: Tests of significance of differences between groups were not performed. 
a CCI=Charlson Coorbidity Index . bHTN=hypertension, cDM=Diabetic Complications. dCOPD=Chronic 
Obstructive Pulmonary Disease.  eMI=myocardial infarction. fCVD=Cerebrovascular disease.  gPVD=peripheral 
vascular disease, hStroke=CVD with hemiplegia, DM=Diabetes Mellitus. 
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Research Questions 
RQ 1: What is the prevalence of frailty in UI/OAB-HF patients?   
Prevalence reflects the proportion of the population that manifests a disease or illness.  
The prevalence of frailty was determined by calculating the number of subjects in the total 
sample and by age group, sex, and race with three or more frailty characteristics (Table 4.5).   
Table 4.5. 
Prevalence of Frailty in Hospitalized Sample of Heart Failure Patients 
Groups Group Totals Frail Mantel-Haenzel Chi-Square
N N (%)a df Value Prob
Total Sample 154 58 (38)
Age groups 1 2.748 .097
Younger 77 24 (31)
Older 77 34 (44)
Sex 1 7.896 .005
 b
Male 90 25 (28)
Female 64 33 (52)
Race 1 0.910 .340
Black 43 18 (42)
White 111 40 (36)
Note:  a (%) = Prevalence: the number of frail in a group divided by the total number in a group.  
bComparisons by sex not stratified by age group. 
The M-H W2 test of significance for differences in proportion frail by age group, sex, or 
race was performed.  Fifty-eight patients had three or more frailty characteristics; a prevalence of 
38% (N=154). Frailty was present in a higher proportion of females (52%) compared to males 
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(28%). Differences in prevalence were statistically significant by sex (p=.005) but not by age 
group or race (Table 4.5).    
RQ 2: Do frailty characteristics observed in UI/OAB-HF subjects differ in frequency between 
male and female, and/or Black and White subjects?   
 Even though frailty has been portrayed as a wasting disorder, and characterized as 
unintentional weight loss and sarcopenia (Buchner & Wagner, 1992; Fried et al., 2001) only five 
subjects were found to have a BMI<18.5 kg/m2 (Table 4.6), the cut-off for underweight  
 
Table 4.6. 
 
Frailty Characteristics by Sex When Controlling for Age.  Cochran-Mantel-Haenszel  
 
Test of General Association.   
Total Male Female Cochran-Mantel-Haenszel 
 
N=154
N (%)
n=90 
N (%)
n=64 
N (%) df Value Prob
Odds 
Ratio 95% CI 
 
Low BMIa 5 (3) 3 (3) 2 (3)
High BMIb 69 (45) 33 (37) 36 (56) 1 6.152 .013 2.29 1.18-4.47
Low Hgbc 75 (49) 19 (21) 56 (87) 1 64.822 <.0001 26.85 10.8-66.9
Low Albumind 77 (50) 41 (46) 36 (56) 1 1.184 .277 1.44 0.75-2.77
Late HFe 104 (68) 65 (72) 39 (61) 1 2.471 .116 0.58 0.29-1.17
Exhaustionf 27 (18) 13 (14) 14 (22) 1 1.815 .178 1.79 0.78-4.16
Note. aLow BMI=BMI<18.5 kg/m2; bHI-BMI= >30 kg/m2; cLow HGB=Hemoglobin <13.5 g/dl if male or <12.5 
g/dl if female; dLow Alb=Albumin <3.8 g/dl; eLate-HF= ejection fraction <40% or NYHA Class HF >III; 
fExhaustion=Iowa Fatigue Scale score>35. 
 
determined by the WHO.   All of the subjects with low BMI were over 65 years old but only 
three met the criteria for frailty; 2% of the total study population.  The majority of subjects with 
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obesity (> BMI of 30 kg/m2) were female (52%), White (66%), and were not frail (55%).  Female 
subjects were more than twice as likely as male subjects to be obese (Table 4.6); the odds by race 
were not significantly different. 
Table 4.7. 
 
Frailty Characteristics by Race When Controlling for Age.  Cochran-Mantel-Haenszel  
 
Test of General Association.   
Total Black White Cochran-Mantel-Haenszel 
 
N=154 
N (%) 
n=43  
N (%) 
n=111 
N (%) df Value Prob 
Odds 
Ratio 95% CIh
Low BMIb 5 (9) ---a 5 (5)
High BMIc 69 (45) 23 (53) 46 (41) 1 1.637 .201 0.63 0.31-1.28
Low HGBd 75 (49) 28 (27) 47 (42) 1 7.226 .007 2.76 1.30-5.83
Low Albumine 77 (50) 20 (47) 57 (51) 1 0.068 .794 1.10 0.54-2.27
Late HFf 104 (68) 34 (79) 70 (63) 1 4.088 .043 2.31 1.01-5.30
Exhaustiong 27 (18) 9 (6) 18 (16) 1 0.271 .603 0.78 0.32-1.93
Note: a No observations fit this category.  bLow BMI=BMI<18.5 kg/m2. cHI-BMI=BMI>30 kg/m2. dLow 
HGB=Hemoglobin <13.5 g/dl if male or <12.5 g/dl if female. eLow Alb=Albumin <3.8 g/dl; fLate-HF= ejection 
fraction <40% or NYHA Class HF >III. gExhaustion=Iowa Fatigue Scale score>35. Frailty= combination of 
three or more characteristics.  hCI= Confidence Interva l. 
Seventy-five subjects met the criteria for anemia (49%, N=154; Table 4.6); 37 of whom 
were considered frail (64%, n=58; see Appendix Table B.1).  Significant differences were found 
in frequency of anemia both by sex (CMH=64.8203; df=1; p<0.0001) and by race (CMH= 
7.2264, df=1; p=0.007) when stratified by age group (Table 4.6 & 4.7).  No statistically 
significant differences in frequency of low albumin were found by sex or by race when 
controlling for age (Tables 4.6 & 4.7 respectively).  Upon further review of the results, late HF, 
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was the most frequent frailty characteristic (n=104) (operationalized as EF <40% and/or NYHA 
Class III or IV HF).  In fact, 72% of the male and 79% of the Black subjects met the criteria for 
late HF (Table 4.6).  When controlling for age, Black subjects were more than twice as likely to 
be in later stages of HF (Table 4.7) as White subjects.  Statistically significant differences in 
frequency of late HF were found for race but not for sex when controlling for age.   However, in 
those older than 65 years, proportionately more male subjects compared to female subjects were 
in late HF (80% and 59% respectively; M-H W2 = 3.8, df=1, p=.05). A larger proportion of Blacks 
compared to Whites was found to be in late heart failure (79% vs, 63%; p=.04), and to have 
anemia (mean=11.63, SD=1.8, p=.01).  
 The frailty characteristic with the lowest frequency (other than BMI<18.5 kg/m2 that only 
had 5) was exhaustion, operationalized as an IFS score >35.  Only 27 subjects reported 
symptoms of exhaustion; 29% of the frail, and 10% of the not frail subjects (Table 4.6, p.53). No 
statistically significant differences were found for either sex or race. 
RQ 3: What combinations of frailty characteristics are observable in UI/OAB-HF subjects, 
and do they differ by sex or by race?  
Thirteen subjects manifested only one frailty characteristic; all of them were White, nine were 
male and four were female.  Proportionately more male subjects than female subjects were found 
to manifest combinations of only two frailty characteristics (p=.03).  While proportionately more 
female subjects than males were found to manifest combinations of four characteristics (p=.002). 
The percentages of males and females to manifest only three frailty characteristics were not 
significantly different (Table 4.8).  Differences in proportions of Black and White subjects 
manifesting combinations of two, three, four, or five frailty characteristics were small and not 
statistically significant (Table 4.9). 
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Table 4.8. 
 
Frequency by Sex of Combinations of Two, Three, Four, and Five Frailty  
 
Characteristics in Hospitalized Heart Failure Patients 
Mantel-Haenszel Total 
N-154 
N (%) 
Male 
n=90 
N (%) 
Female
n=64 
N (%) df W2 Prob 
 
Combo of Two 32 (21) 24 (27) 8 (13) 1 4.53 .0333
Combo of Three 36 (23) 20 (22) 16 (25) 1 0.16 .6890
Combo of Four 20 (13) 5 (6) 15 (23) 11 10.52 .0012
Combo of Five 2 (1) ---  2 (3) --- --- ---
Note. Combo=Combinations of frailty characteristics 
Table 4.9. 
 
Frequency by Race of Combinations of Two, Three, Four, and Five Frailty  
 
Characteristics in Hospitalized Heart Failure Patients 
Total 
N-154
Black 
n=43
White 
N=111
Mantel-Haenszel 
N (%) N (%) N (%) df W2 Prob 
Combo of Two 32 (21) 11 (26) 21 (19) 1 0.83 .362
Combo of Three 36 (23) 9 (21) 27 (24) 1 0.198 .656
Combo of Four 20 (13) 8 (19) 12 (11)  1 1.66 .198
Combo of Five 2 (1) 1 (2) 1 (1)  --- --- --- 
Note. Combo=Combinations of frailty characteristics.  
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The M-H test of association was used to test the significance of differences in frequency 
of combinations of frailty characteristics by sex and by race.  However, the tables that were 
created for individual combinations of two or more frailty characteristics had a large number of 
cells with no observations.  Consequently, tests of significance were not performed for this part 
of the analysis and only frequency counts are being reported (Table 4.10). 
Out of the 14 combinations of two frailty characteristics, only three occurred in five or 
more subjects.  For example, a higher percentage of male subjects had either combinations of 
anemia with late HF, or low albumin with late HF, while the combination of anemia with low 
albumin was manifested by a slightly higher percentage of female subjects.  Similarly, out of the 
16 combinations of three criteria, only two were found to occur in five subjects or more, obesity 
with low albumin and late HF was found in a slightly higher percentage of male subjects, while 
anemia with low albumin and late HF was found in a higher percentage of female subjects.  Only 
one of the nine combinations of four occurred in more than five subjects. The combination of 
obesity with anemia, low albumin and late HF was found in 16% of female subjects and no 
males. Finally, only two subjects manifested one of the two combinations of five characteristics; 
both of them were underweight women (BMI <18.5 kg/m2) (Table 4.10).  Two combinations of 
two frailty characteristics, anemia with Late HF and Low Albumin with Late HF, were found to 
occur in a higher percentage of Blacks than Whites, while a higher percentage of Whites 
manifested the two combinations of three described above.   
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Table 4.10. 
 
Examples of Combinations of Frailty Characteristics: Combinations with the Highest Frequency 
Unique Combinations of Frailty Characteristics 
Total Male Female Black White 
N-154 
N (%) 
n=90 
N (%) 
n=64 
N (%) 
n=43 
N (%) 
n=111 
N (%) 
 COMBINATIONS OF TWO
H-BMIa/Lt-HFb 4 (3) 4 (4) --- 1 (2) 3 (3) 
L-HGBc/L-Albumind 5 (3) 1 (1) 4 (6) 1 (2) 4 (4) 
L-HGB/Lt-HF 6 (4) 4 (4) 2 (3) 4 (9) 2 (2) 
L-Albumin/Lt-HF 14 (9) 14 (16) --- 5 (12) 9 (8) 
 COMBINATIONS OF THREE
H-BMI/L-HGB/L-Albumin 4 (3) --- 4 (6) 2 (5) 2 (2) 
H-BMI/L-HGB/ Lt-HF 3 (2) 2  (2) 1 (2) 3 (7) --- 
H-BMI/ L-Alb/Lt-HF 11 (7) 8 (9) 3 (5) 2 (5) 9 (8) 
L-HGB/ L-Alb/Lt-HF 11 (7) 4 (4) 7 (11) 2 (5) 9 (8) 
L-Alb/LateHF/ Exhaustione 3 (2) 3 (3) --- --- 3 (3) 
 COMBINATIONS OF FOUR
H-BMI/ L-HGB/ L-Alb/Lt-HF 10 (6) --- 10 (16) 3 (7) 7 (6) 
H-BMI/ L-HGB/ L-Alb/ Exhaustion 3 (2) --- 3 (5) 1 (2) 2 (2) 
HI-BMI/ L-Alb/Lt-HF/ Exhaustion. 4 (3) 4 (4) --- 2 (5) 2 (2) 
 COMBINATIONS OF FIVE
L-BMIf/ L-HGB/ L-Alb/Lt-HF/ Exhaustion 2 (1) --- 2 (3) 1 (2) 1 (1) 
Note. aH-BMI=BMI>30 kg/m2; bLt-HF= ejection fraction <40% or NYHA Class HF >III; cL-Hgb=Hemoglobin 
<13.5 g/dl if male or <12.5 g/dl if female; dL-Alb=Albumin <3.8 g/dl; fExhaustion=Iowa Fatigue Scale score>35.  
gL-BMI=BMI<18.5 kg/m2.   
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RQ 4:  Are relationships observed between frailty and comorbidity, depression, needing help 
with IADLs, poor health, or UI in UI/OAB-HF subjects?      
Five covariates that have appeared in the literature as risk factors for frailty were selected 
from the UI/OAB-HF database for analysis: depression, UI, poor self-rated health, disability 
(needing help with IADLS), and comorbidity (two or more concurrent chronic illnesses).  Both 
descriptive and exploratory statistical methods were performed to determine the degree of 
association between frailty, age group, sex, and race, and the five covariates listed above.   
First, CMH tests of General association were performed with the contingency tables 
stratified by age, and with one of the five covariates as the row variable and either sex or race as 
the column variable.  Three out of five of the covariates achieved significance by sex (Table 
4.10), but no differences were found by race when stratified by age (4.11).   Females 
Table 4.11. 
 
Comparisons by Sex of Frequencies of Covariates in Hospitalized Heart Failure Patients 
Total Male Female   Cochran-Mantel-Haenzel GA   
N=154 n=90 n=64 
Covariates N (%) N (%) N (%) df Value Prob ORf 95% CIg
Depressiona 54 (35) 26 (29) 28 (44) 1 4.21 .04 2.05 1.03 4.07
Poor Healthb 115 (75) 68 (76) 47 (73) 1 0.006 .94 0.83 0.36 1.91
UIc 78 (51) 34 (38) 44 (69) 1 13.30 .0003 3.28 1.63 6.61
Disabilityd 31 (20) 12 (13) 19 (30) 1 4.97 .03 2.53 1.03 6.19
Comorbiditye 129 (84) 75 (83) 54 (84) 1 .0008 .98 1.01 0.42 2.46
Note. aDepression=Score >14 on CES-D.  bPoor Health=Self-report of fair or poor health. cUI=Urinary 
Incontinence. dDisability=needs help with >ADLs.  eComorbidity=>2 concurrent chronic illnesses.  fOR=Odds 
Ratio. gCI= 95% Confidence Intervals. 
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Table 4.12.   
 
Comparisons by Race of Frequencies of Covariates in hospitalized Heart Failure Patients 
Total Black White Cochran-Mantel-Haenzel GA  
N =154 n=43 n=111
Covariates N (%) N (%) N (%) df Value Prob ORf 95%CIg
Depressiona 54 (35) 14 (33) 40 (36) 1 0.33 .57 1.22 0.58 2.60
Poor Healthb 115 (75) 33 (77) 82 (74) 1 0.01 .92 0.97 0.41 2.26
UIc 78 (51) 23 (53) 55 (50) 1 0.42 .51 0.79 0.38 1.61
Disabilityd 31 (20) 8 (19) 23 (21) 1 0.00 .95 0.90 0.35 2.32
Comorbiditye 129 (84) 36 (84) 93 (84) 1 0.03 .87 1.31 0.45 3.79
Note. aDepression=Score >14 on CES-D.  bPoor Health=Self-report of fair or poor health. cUI=Urinary 
Incontinence. dDisability=needs help with >ADLs.  eComorbidity=>2 concurrent chronic illnesses.  fOR=Odds 
Ratio. gCI= 95% Confidence Intervals. 
were twice as likely to be depressed as males (p=.04), nearly 3 times as likely to need help with 
IADLS (p=.03), and more than three times as likely to report UI (p=.03) as males.   
Next, two logistic regression models were tested.  Age was statistically controlled in this analysis 
to reduce the effect of age created by the greater longevity of females and Whites.   
Next, two logistic regression models were fitted; the first one with individual explanatory 
variables, the second model added interaction terms to the firs model.  Age group, sex, and race 
were included in all models.  Depression, poor health, UI, disability, and comorbidity were added 
to the first model and a backward selection procedure was performed.  The level of significance 
for individual variables to remain in the model was set at a p level <.05.    
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Table 4.13. 
Comparison of Binary Logistic Regression Model Fit Statistics: First and Second Model 
Criterion Intercept +  Covariates
First model:  AIC 183.06
Second model:  AIC 181.79
Note. First model refers to: Frailty=age group +sex + poor health + comorbidity. Second model refers to: Frailty=age 
group + sex + race + poor health + comorbidity + race*age group AIC=Akaike’s information criterion 
Table 4.14. 
 
Comparison of Tests of Global Null Hypothesis: BETA=0, For Two Binary 
 
Logistic Regression Models  
Test Chi-Square df Pr > ChiSq
First Model Wald 22.81 4 .0001
Second Model Wald 25.78 6 .0002
Note. First model refers to: Frailty=age group +sex + poor health + comorbidity. Second model refers to: 
Frailty=age group + sex + race + poor health + comorbidity + race*age group AIC=Akaike’s information 
criterion  
Interaction terms for all possible pairings between age sex, race, and the two remaining 
covariates, poor health and comorbidity, were then added to the model (nine total) and logistic 
regression with backward selection was performed a second time.  The second model proved to 
be a better fit for the data when the change in AIC from model one to model
Table 4.15.
Binary Logistic Regression: Analysis of Maximum Likelihood and Odds Ratio Estimates for Second Model.
Parameter df Estimate Std. Err
Wald
Chi-Square Pr > ChiSq Odds Ratio
95% Wald
Confidence Limits
Intercept 1 -4.717 1.130 17.428 <.0001 --- --- ---
Age group 1 2.976 1.239 5.772 .016 19.611 1.730 222.327
Sex 1 1.219 0.393 9.641 .002 3.385 1.568 7.309
Race 1 1.273 0.421 9.151 .003 3.570 1.565 8.144
Poor health 1 1.679 0.541 9.617 .002 5.360 1.855 15.490
Comorbidity 1 1.210 0.596 4.119 .042 3.353 1.042 10.786
Age Group*Race 1 -1.911 0.898 4.532 .033 0.148 0.026 0.859
Testing Null: BETA=0 6 --- --- 25.78 .0002 --- --- ---
Note. Age groups were 50-65 years and 65 years and older.
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two (25 points) was determined (Table 4.13).  The Wald Chi-square test, (W2 =23.3657, df=14, 
p=.05) indicated that the null hypothesis, Beta=0, could be rejected (Table 4.14).  From the 
second model it was determined that female sex increased the odds of frailty being present by 
more than three times that of male sex in hospitalized HF patients.   Frailty was 3.5 times more 
likely when self-report of health was “fair” or “poor” than when health was rated good or 
excellent, and more than five times more likely in the presence of two or more concurrent chronic 
illnesses (Table 4.15).  Furthermore, the only interaction found to have a significant influence on 
the odds of frailty was that between age group and race.  
Summary 
This chapter began with a description of sample characteristics using demographics, 
clinical assessment measurements, and diagnostic categories.  This description was followed by a 
report of the results of specific data analyses performed to answer each RQ.  Data from 154 
participants in the UI/OAB-HF study were analyzed.  The sample was predominantly male (58%) 
and White (72%) with an equal number (n=77) of subjects 50-64 years and >65 years and older.  
A higher percentage of males (67%) were married while proportionally more females were 
unmarried (55%, p= .04).   
 The prevalence of frailty in this sample of hospitalized HF patients (N=154) was 38 
percent.  Statistically significant differences were found between males and females and between 
Blacks and Whites, with p levels of .05 to .001 when comparing prevalence, frailty 
characteristics, combinations of frailty characteristics, and relationships among covariates.  More 
female subjects were frail (p=.005) compared to males while controlling for age (RQ1).  Higher 
proportions of female subjects were obese (p=.01) or anemic, while (p=.03) when age was held 
constant, while more older-men had late HF (p=.05) than older women.  When frailty 
characteristics were examined by race, a greater proportion of Black subjects were anemic 
(p=.01) or in late HF (p=.05) (RQ2).  A significantly greater percentage of men manifested only 
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two frailty characteristics (p=.03), and a significantly greater percentage of women were found to 
have four frailty characteristics (p=.001) (RQ3).  Finally, the best model fit using logistic 
regression found that sex, perceived poor health, and comorbidity independently increased the 
odds for frailty, while an interaction effect was found between age and race (RQ4). In the next 
chapter the implications of these results will be discussed. 
 
CHAPTER V 
DISCUSSION 
It is vitally important to the health and well-being of the growing population of older 
adults that nurses strive to better understand frailty. When early indicators of frailty are missed or 
mistaken for “normal” aging, preventable adverse health outcomes occur that then lead to the 
deterioration of an individual’s independence or autonomy, and contribute to skyrocketing health 
care costs. Bortz (2002) has argued that frailty is inherently responsive to lifestyle changes, with 
particular attention to physical activity levels.  In fact, there have been intervention studies 
involving exercise programs that support this premise by demonstrating improvement in 
outcomes associated with frailty  (Gill, Baker, Gottschalk, Peduzzi, et al., 2002; Sattin, Easley, 
Wolf, Chen, & Kutner, 2005). Others have noted that better outcomes were achieved in the 
presence of frailty when a multidisciplinary approach was used to meet health care needs 
(Altimir, 2005; Inouye et al., 2000; Landefeld, Palmer, Laurent, & Hobbs, 2001).   
 The relationships between frailty and sex, or frailty and race are not well known. Few 
studies have discussed sex, race, or age in relation to frailty other than as sample characteristics 
or descriptions of prevalence.  Recently differences in mortality due to frailty by sex (Putts, et al., 
2006) and differences in prevalence by age (Altimir, et al., 2005), and by race (Hirsch, et al., 
2006) have been investigated. The purpose of this study was to explore 
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and describe differences by sex or race in relation to frailty and frailty characteristics in 
hospitalized chronic HF patients. A secondary analysis of data from the UI/OAB-HF study was 
performed as a preliminary study for a future program of research looking at frailty in older 
adults in the acute care setting.  This chapter discusses what was found and how the results 
compare with the frailty literature, as well as the implications for practice and implications for 
future research.  
Assessing Validity for Operational Definition of Frailty  
 Following the example of others (Boyd et al., 2005; Fried et al., 2001; Newman et al., 
2001; Woods et al., 2005), frailty was operationalized as present when at least three of the 
following measures exceeded their established norms:  a) Body Mass Index (BMI) <18.5 kg/m2 
or BMI>30 kg/m2; b) Hemoglobin (Hgb) <12.5 g/dl for women, or <13.5 g/dl for men; c) 
Albumin <3.8 g/dl;  d) Iowa Fatigue Scale (IFS) score>35; and e) Ejection Fraction (EF) < 40% 
or NYHA Class III or IV heart failure.  These measures served as proxies for clinical indicators 
of frailty suggested by the conceptual model and review of literature.  For example, BMI less 
than 18.5 kg/m2 and albumin less than 3.8 g/dl were associated with chronic undernutrition, and 
served as indicators of unintentional weight loss and protein deficiency.  Hemoglobin levels 
characteristic of anemia and an IFS score greater than or equal to 35 (indicating extreme fatigue) 
were associated with energy deficiency, activity intolerance, poor endurance, and exhaustion.  
Lastly, indicators of poor cardiac function (using NYHA classification) and obesity (using WHO 
standards) were associated with decreased activity levels.  Each measure was coded as a zero if it 
fell within normal range and one if the above criteria were met.  This resulted in a frailty score 
with a range of 0-5 where zero indicated those who were least vulnerable and five represented 
those who were the most vulnerable.  
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Because the measures used to operationalize frailty were only approximations of known 
indicators of frailty, there was a need to assess the legitimacy of the frailty score.  Given the 
limitations of the existing data the method chosen was to assess the convergence of the frailty 
score with three measures of concepts hypothesized to be related to the concept of frailty --- 
mortality risk, depression, and fatigue.  Three instruments --- the CCI, CES-D, and the IFS --- 
were used to examine the validity of the frailty score as a multidimensional construct.  The CCI 
represents physiological aspects, the CES-D represents psychological aspects, and the IFS 
represents functional vulnerability or decline.  It was hypothesized that if frailty scores correlated 
positively, substantially, and significantly with these three instruments evidence of the construct 
validity of the frailty score would exist.  
 Spearman’s correlation coefficients were calculated between the frailty score and the 
CCI, CES-D, and IFS.  The frailty score correlated positively and significantly but not 
substantively.  The obtained correlations (r=.28 with CCI .28 with CES-D and .38 with IFS; 
n=154) were acceptable as providing some evidence of construct validity.  However, these 
correlations were not large enough to assure construct validity of the frailty score.       
Sample Characteristics 
 The rationale for selecting the UI/OAB-HF database was based on evidence of a strong 
association between frailty and HF increasing the likelihood of having a large enough sample of 
frail subjects to analyze. Heart failure patients have been reported to be almost eight times more 
likely to be frail than patients with other types of cardiovascular diseases (Newman et al., 2001), 
and characteristically experience increasing functional decline with worsening HF (Altimir et al., 
2005). Approximately one out of every three subjects in this study was frail (38%); a large 
enough sample of frail subjects to perform most of the statistical analyses as planned. However, 
the sample was too small (n=58) to perform a detailed analysis of unique combinations of frailty 
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characteristics. This was disappointing, but helpful, as the need for a larger sample became 
apparent.        
 Studies of frailty frequently exclude subjects younger than 65 years as the age of 65 is 
considered the beginning age of older adulthood.  In this study 34 percent of HF patients 50 to 65 
years old met the criteria for frailty.  This is consistent with the findings of Altimir and 
colleagues (2005) in which 33 percent of subjects younger than 65 years met their frailty criteria, 
and supports the notion that old age is a risk factor but not necessarily a characteristic of frailty. 
Strengths and Limitations 
Obviously, there are limitations to doing a secondary analysis.  One of the biggest of 
them is not having control over which data are collected or how variables are measured.  In this 
case several of the variables selected to measure frailty were results obtained by standardized 
medical protocols and part of the patient database and would be the same no matter who 
collected them.  What is not clear is whether they were collected on admission or during a crisis 
vs. after being stabilized.  Inconsistency in the battery of lab tests ordered or assessments 
performed was unavoidable and resulted in missing data on two key frailty characteristics: 
NYHA classification for HF and albumin level.  By using ejection fractions <40% in place of 
missing NYHA class III or IV HF data a male bias may have been introduced for the Late HF 
criterion.  A similar compromise was not available for missing albumin results and frailty may 
have been under-represented as a result. Also, even though a random sample is not required for a 
descriptive study, the use of a convenience sample limits the degree to which results can be 
generalized to other populations. 
 One of the strengths of this study was that the definition of frailty used was comparable 
to that used in earlier studies.  By basing the definition primarily on objective measures, the risk 
71
of researcher bias and error were reduced. In addition, by including subjects younger than 65 
years, it was shown that frailty is a concern for an even larger population than just older adults. 
Discussion of Major Findings 
Prevalence of Frailty 
Prevalence estimates depend on the definition of frailty and the measures used to identify 
frailty characteristics.  A conceptual model of frailty describing a circular relationship among 
three core physiological processes was the basis for the definition used in this study.   Five 
indicators of functional decline related to these three processes were measured.  Frailty was 
considered to be present when any three of the five criteria were met.   Using the 
preceding definition for frailty, a prevalence of 38 percent was found in the UI/OAB-HF 
database. This is higher than the baseline prevalence reported by several longitudinal studies with 
large samples of community dwelling adults over 65 years ranged from six to seven percent in 
the CHS study (Boyd et al., 2005; Fried et al., 2001; Newman et al., 2001), 16 percent in WHIS 
(Woods, 2005), and from 14 to 25 percent in WHAS I (Chaves et al., 2005).  Finding a such a 
high prevalence in a sample of HF patients when using the above definition was not surprising 
considering the findings of Newman et al. (2001) that CHS participants who had HF were eight 
times more likely to be frail than subjects with other cardiovascular diseases.  In addition, as was 
mentioned earlier, Altimir and colleagues (2005) also found a higher prevalence of what they 
called “fragility” (41%) in a population of HF patients.  Their definition was based on evidence 
of lost autonomy in performing ADLs, cognitive deterioration, emotional disturbance, and social 
risk; all known antecedents or outcomes of frailty.   
 Prevalence was found to differ by sex but not by race.  A significantly higher prevalence 
was found in female subjects than males (52% vs. 28%, p=.005) even when controlling for age.  
While finding a higher prevalence in females is not new, it was thought to be the result of the 
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greater longevity of women.  Fries (2005) noted that while women have greater longevity than 
men, they also run the risk of accumulating a greater number of chronic illnesses with 
accompanying disabilities that increase their risk for frailty, although the current study found that 
female CCI scores, a measure based on accumulated chronic illnesses weighted for severity, were 
not significantly different from those of male subjects (p=.07).  
Frailty Characteristics 
Differences were found between male and female as well as Black and White subjects 
both in frequency and number of frailty characteristics.  The five variables used to operationalize 
frailty were chosen because they were the clinical measures in the UI/OAB-HF database that 
most closely resembled the phenotype of frailty used by others (Boyd et al., 2005; Chaves et al., 
2005; Fried et al., 2001; Newman et al., 2001; Woods, et al., 2005), and were the best measures 
available to indicate declines in the following three physiological processes:  a) nutrition, or 
energy supply based on demand, b) energy storage, or energy delivery based on supply, c) energy 
expenditure, based on delivery (see Figure 3.1).   
When overall sample results were compared by sex, obesity (BMI>30 kg/m2 p<.01) and 
anemia (HGB <12.5 g/dl for women, <13.5 g/dl for men, p<.0001) occurred more frequently in 
women compared to men when age was held constant (Table 4.6, p. 59), while late HF (EF<40% 
or NYHA Class HF >III, p<.05, N=154) occurred more frequently in older men than older 
women.  No statistically significant differences were found in the frequency of either low 
albumin (albumin <3.8 g/dl) or exhaustion (IFS score >35) by sex (Table 4.6).   
When just the subjects who were frail (n=58) were compared, frail women were no more 
likely to be obese than frail men, and frail men were only 21% more likely to be in late HF than 
frail women (See Appendix B, Table B.1).  It was possible that the differences in anemia were 
more characteristic of HF than frailty as well.  However, frail women were 27 times more likely 
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than frail men to be anemic when age was held constant (Table B.1). Anemia has been found to 
be a significant predictor of death in HF subjects, even at low normal range and has been 
associated with worsening symptoms (Horwich, Fonarow, Hamilton, MacLellan, & Borenstein, 
2002; Szachniewicz et al., 2003). The finding that frail women were 27 times more likely to be 
anemic than frail men is an important finding that indicates a possible area of vulnerability for 
women that differs for men.  A closer look at anemia in frail women could reveal unique 
predictors of frailty that will lead to earlier detection of risk of frailty, and indicate more 
aggressive treatment of anemia in women. 
Frequencies for frailty characteristics in the overall sample were also compared by race 
(N=154).  No differences were found in the frequency of obesity, hypoalbuminemia, or 
exhaustion.    Black subjects were nearly three times more likely to be anemic, and twice as 
likely to be in late HF than White HF patients holding age constant (Table 4.7, p. 60).  The latter 
finding could be related to the high prevalence of hypertension (a risk factor for HF) in the Black 
population (AHA, 2005).  No differences were found by race in the frequency of low albumin 
level or exhaustion in the overall sample (Table 4.7).  However, when frail subjects were 
compared by race, a significantly higher proportion of White subjects had hypoalbuminemia 
compared to blacks (p=.05) (see Appendix B, Table B.2). 
Frailty has been called a wasting disorder, characterized by the loss of fat free mass 
(Walston, 2005), so it was most surprising to only find 5 subjects with a BMI <18.5 kg/m2 and 
only two of them also frail.  Both frail subjects had the maximum score for frailty; a score of five.  
The frailty characteristic being measured here was chronic under nutrition, or failing to meet 
biological needs for nutrients, called “shrinking” or “unintentional weight loss” by Fried and 
colleagues (Fried, 1999; Fried et al., 2001).  It is possible that a BMI characteristic of someone 
severely underweight is a late indicator of frailty. Furthermore, the finding that high BMI was not 
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significantly different by sex when only the frail data were examined suggests that fluid 
retention, commonly associated with HF, may be confounding these results.   
There were 69 subjects with a BMI >30 kg/m2, three were morbidly obese with a BMI 
>50 kg/m2, and 31 of them were frail.  Obesity has been found to lead to slower walking speeds, 
reduced energy expenditure, and a four-fold increase in the odds of being frail (Woods et al., 
2005).  Woods et al. determined that there was a U-shaped relationship between BMI and frailty 
in which both a BMI <18.5 kg/m2 and a BMI>30 kg/m2 were associated with frailty. This 
suggests that skeletal muscle mass, characteristic of frailty and undernutrition, can be lost even in 
the presence of obesity.  Only two subjects were found to have at least five frailty characteristics; 
both subjects were underweight, while one of the three morbidly obese subjects only met two 
frailty criteria.  Further study is needed to explore the role of extremes in weight as indicators of 
frailty.      
Sarcopenia, or loss of lean muscle, which is easily associated with low BMI, has recently 
been associated with physical frailty in the obese elderly (Villareal et al., 2004).  While 
sarcopenia is a significant finding with regard to unintentional weight loss, it cannot be 
overlooked as a concern in obesity as well.  One study of protein supplementation in older 
women found that frail women had a higher rate of protein synthesis and breakdown than healthy 
women but net protein balance was about the same as that of healthy women (Chevalier, 
Gougeon, Nayar, & Morais, 2003).  Corti et al. (1994) found that low albumin <3.5 g/dl was the 
result of a prolonged period of poor nutrition, and of sarcopenia, an indicator for frailty.  While 
Visser et al. (2005) found that even albumin <3.8 g/dl had increased risk for sarcopenia.  It was 
expected that low albumin would be accompanied by a higher frequency of low BMI (BMI <18.5 
kg/m2), which is indicative of someone who is underweight for height.   In actuality, fewer than 
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50 subjects had a BMI less than 25 kg/m2 , the high end of normal range, and only 10% of those 
had a BMI <18.5 kg/m2.    
Ninety-two subjects met the criteria for anemia controlling for sex; 37 of whom were 
frail.  Chaves et al. (2002) found that those with a hemoglobin <12.5 gm/dl (they did not 
discriminate between the sexes) had a 60% probability of mobility difficulty with associated loss 
of strength and power.  They also found that those with low normal HGB (13.0-14.5 g/dl) had a 
significantly greater likelihood of being frail compared to those with HGB in mid range or 
higher.  While the risk that accompanies blood transfusions may outweigh the benefit in younger 
populations except at very low HGB levels, it is possible that, in the case of the older adult 
population, the benefits outweigh the risk. 
Not surprisingly, the frailty characteristic with the highest frequency in this sample of HF 
patients was symptomatic late HF (ejection fraction <40%, or NYHA Class IV HF).  NYHA 
classification of HF is based on subjective symptoms of increasing distress (e.g. dyspnea or poor 
endurance) associated with decreasing levels of activity (NYHA, 1994).  It was expected that 
those with symptomatic HF would also experience severe fatigue.   However, severe fatigue was 
the frailty characteristic with the lowest frequency; only 27 (18%) subjects out of 154 scored 
higher than 35 on the 10-item fatigue scale.  It is conceivable that some HF patients would reduce 
their activity level to compensate for changes in activity intolerance and so would not experience 
fatigue as acutely.  This finding needs exploration including discovery of whether women are 
more inclined to reduce activity levels in this situation than men. 
Subjects were grouped according to the number of frailty characteristics present.  Even 
though significance of differences could not be tested due to sample size, some interesting trends 
were noted.  Table 4.7 presents the combinations of frailty characteristics that had the highest 
frequencies.  Male subjects had fewer frailty characteristics than females, and the combination of 
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characteristics to occur most often was obesity/low albumin/late HF.  Female subjects had a 
higher number of different combinations of frailty characteristics.  Of those females who were 
frail, a combination of four frailty characteristics (obesity with Low HGB, Low Albumin and 
Late HF) occurred with the highest frequency. These findings are consistent with those of Puts et 
al. (2005) who found that women accumulated more frailty markers than men.   
If frailty is to be measured by the number of criteria met, then female subjects should be 
more frail, i.e. more vulnerable to adverse outcomes.  Yet, when only baseline frailty was 
compared, the relative risk of mortality of men compared to women was about the same (Puts et 
al., 2005).  However, when changes over time were compared, the relative risk of mortality for 
women was higher when they experienced a downward trend in any functional domain, while the 
relative risk for men increased only with increased depression or decreased weight.  Perhaps 
women have a higher threshold for morbidity and become symptomatic when less than 70% of 
functional reserves are lost as Bortz (2002) suggested.  If this is so, women may respond well to 
interventions focused on maintaining current level of function.  Or perhaps more early indicators 
of frailty for women have been identified and men are being identified at a later stage.  Further 
research is warranted to compare men and women not only in terms of the number and types of 
frailty characteristics, but whether they differ in terms of early indicators of vulnerability.  
Associations between Frailty and Covariates  
Sex was found to be a strong individual predictor of frailty independent of age. In fact, 
the odds of being frail and female were 3 fold higher than that of being frail and male (Table 
4.14) at any age.   Advanced age was expected to increase the odds of frailty when combined 
with sex because a higher prevalence of frailty was found in the older age group and in female 
subjects. However, an interaction between sex and age group was not found in this study.   
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Relationships found between frailty and comorbidity, depression, disability, perceived 
poor health and UI were similar to the findings of previous research.  For example, most of the 
participants in the UI/OAB-HF study were found to have scores greater than or equal to ten on 
the CES-D, indicating the presence of depressive symptoms.  More than a third of the total 
sample and half of frail group were found to score greater than or equal to fourteen on the CES-D 
making it highly likely they were depressed in mood.   Boyd et al. (2002) reported a prevalence 
of 14 percent for depression in a sample from the WHIS study using the same instrument, and 
Woods and colleagues (2005) found 24 percent of their frail subjects from the WHAS-I study 
were depressed. Both study populations were female. In the current study females were more 
than twice as likely to be depressed as male subjects.   Fried and others (2001) found depressive 
symptoms in 9.9% of their CHS sample of both male and female subjects, and in 31% of those 
who were frail.   
 The majority of the sample had more than two additional chronic illnesses (84%), and 
neither male and female nor Black and White subjects differed significantly.   Other studies have 
reported between 68 to77 percent of subjects to have comorbidity (Fried et al., 2001; Woods et 
al., 2005). In this study, hospitalized HF patients were more than five times as likely to be frail 
when they were diagnosed with two or more additional chronic illnesses.    
Even though UI did not prove to be a significant indicator for frailty, it was present in 
51% of the sample; and in significantly more female than male subjects (69% and 38% 
respectively; p<.0001).  Similarly, even though only 20% of the sample acknowledged needing 
help with IADLs, the difference between male and female subjects was statistically significant 
(13% and 30%; p=.03).    
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Implications for Nursing  
This was a preliminary study so it is difficult to draw conclusions from the results that 
would directly impact the practice of nursing.  Significant differences in prevalence of frailty, 
number and type of frailty characteristics were found by sex but not by race.  It was most 
interesting to find that frail women were 27 times more likely to be anemic than frail men.  
Nurses have a role in educating patients and families in important ways such as dietary 
modifications or exercise programs to avert complications related to anemia.  Furthermore, it is 
important for nurses to understand the role of obesity in frailty.  It is sarcopenia, not low weight 
that has been found to lead to adverse outcomes and increase mortality.  Therefore it is important 
to ensure that obese patients receive adequate nutrition to reduce the loss of skeletal muscle mass 
that accompanies malnutrition.     
Implications for Research   
The aim of future nursing research should be to assist nurses to better identify those who 
are frail, make identifications earlier, and target treatment strategies to maintain optimal quality 
of life.  Further study needed to explore role of extremes in weight to height ratio and its 
significance in frailty.  Further research needed to explore the role of fatigue and reduction in 
activity level: are women more likely than men to reduce activity levels to avoid feeling fatigue?  
Further research is warranted to compare men and women not only in terms of number and types 
of frailty characteristics, but whether they differ in terms of early indicators of vulnerability. 
Where to from here? 
 One direction for future study will be directed toward understanding the role of 
compensatory mechanisms, used by those who are frail to manage functional decline, and the 
development of frailty.  In this study only 27 subjects reported significant symptoms of fatigue 
yet 68 percent of the overall sample and 86 percent of those who were frail were determined to 
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be in late HF (Class III or IV).  What were they doing so as not to experience fatigue?  Could 
these compensatory mechanisms increase the risk for frailty?     
Conclusion 
This study used the frailty phenotype introduced by Fried and colleagues (2001) as a 
basis for defining frailty in hospitalized HF patients who are in middle (50-65 years) to extreme 
(>85 years) old age.  A strong association between frailty and HF was supported by finding a 
substantially higher prevalence of frailty in the study sample of hospitalized HF patients 
compared to the prevalence found by others in heterogeneous samples of community dwelling 
older adults.  Sex was found to be an important predictor of frailty (p=.002) whereas race was 
not.  Differences in number and type of frailty characteristics found between male and female as 
well as Black and White heart failure patients warrant further study with a larger population 
studied over time to determine the role of HF in the development of frailty.  Interventions 
targeting specific areas of vulnerability such as anemia and sarcopenia may be effective in 
reversing or delaying the onset of frailty.
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Appendix A: 
Operational Definitions 
Comorbidity: The concurrent presence of two or more medically diagnosed diseases in the 
same individual. 
Depression: indicated by: a score of >14 on CES-D.  
Disability: difficulty with or needing help with one or more instrumental activities of daily 
living (IADLs). 
Frailty:  when 3 or more of the following are present: 
a. Hypoalbuminemia (serum Albumin < 3.8 g/dl)  
b. Anemia (hemoglobin < 12.5 g/dl for women or < 13.5 g/dl for men) 
c. Exhaustion indicated by a score >35 on the Iowa Fatigue Scale. 
d. Ejection fraction < 40% or NYHA Class IV HF 
e. Body mass index (BMI) <18.5 kg/m2 or >30 kg/m2
Obesity: Body mass index >30 kg/m2. 
Poor Health Status: indicated by responding with a three or four to the question: “How 
would you rate your current overall health?”  
Underweight: Body mass index <18.5 kg/m2. 
Urinary Incontinence indicated by score > 1 on ICIQ.  
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Appendix B 
 
Tables 
Table B.1.   
 
Comparison by Sex of Frailty Characteristics of Frail Subjects  
Male Female  Cochran-Mantel-Haenzel  Total 
Frailty 
Criteria  
 n=25 
N (%) 
n=33 
N (%) df W2 Prob Logit 95% C L 
N=58
N (%)
Low BMI 1 1 2 (3)
High BMI 17 (68) 23 (70) 1 1.15 .28 40 (69)
Low HGB 7 (28) 30 (90) 1 23.66 <.0001 27.4 6.07-2123. 37 (64)
Low 
Albumin 21 (84) 31 (94) 1 1.15 .28 52 (90)
Late HF 24 (96) 26 (79) 1 3.70 .05 0.21 0.03-1.40 50 (86)
Exhaustion 10 (40) 7 (21) 1 1.88 .17 17 (29)
Note. Odds ratio calculated by Cochran-Mantel-Haenzel test and groups stratified by age. 
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APPENDIX B-2 
 
Table B.2. 
 
Comparison of Frailty Characteristics of Frail Subjects: by Race 
Black White
Mantel-
Haenzel Total
n=18 n=40 N=58
Frailty Criteria N (%) N (%) df W2 Prob  N ( %)
Low BMI -- 5 (5) 0.9161 .33 2 (3)
High BMI 15 (83)  25 (63 1 2.474 .12 40
Low HGB 14 (78) 23 (58) 1 2.1718 .14 37
Low Albumin 14 (78) 38 (95) 1 3.9015 .05 52
Late HF 15 (83) 35 (88) 1 0.1781 .67 50
Exhaustion 6 (33) 11 (28) 1 0.2004 .65 17
Note.  Mantel-Haenzel Chi-Square test of significance was performed.  Groups were not stratified by 
age. 
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